KR20010041916A - 스타틴-매트릭스 메탈로프로테이나제 저해제 복합제제 - Google Patents

Info

Publication number

KR20010041916A

KR20010041916A KR1020007010223A KR20007010223A KR20010041916A KR 20010041916 A KR20010041916 A KR 20010041916A KR 1020007010223 A KR1020007010223 A KR 1020007010223A KR 20007010223 A KR20007010223 A KR 20007010223A KR 20010041916 A KR20010041916 A KR 20010041916A

Authority

KR

South Korea

Prior art keywords

acid

methyl

phenyl

ethyl

oxo

Prior art date

1998-03-17

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Links

• Espacenet
• Global Dossier
• Discuss

• 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 title description 17
• 239000003771 matrix metalloproteinase inhibitor Substances 0.000 title description 17
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims abstract description 85
• 229940124761 MMP inhibitor Drugs 0.000 claims abstract description 58
• 238000011282 treatment Methods 0.000 claims abstract description 33
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 27
• -1 dehydrocomptin Chemical compound 0.000 claims description 579
• 239000002253 acid Substances 0.000 claims description 89
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 82
• 150000003839 salts Chemical class 0.000 claims description 79
• 238000000034 method Methods 0.000 claims description 57
• 125000000217 alkyl group Chemical group 0.000 claims description 43
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 41
• 201000001320 Atherosclerosis Diseases 0.000 claims description 27
• RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 claims description 25
• AJLFOPYRIVGYMJ-UHFFFAOYSA-N SJ000287055 Natural products C12C(OC(=O)C(C)CC)CCC=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 AJLFOPYRIVGYMJ-UHFFFAOYSA-N 0.000 claims description 23
• AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 claims description 23
• BOZILQFLQYBIIY-UHFFFAOYSA-N mevastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CCC=C21 BOZILQFLQYBIIY-UHFFFAOYSA-N 0.000 claims description 23
• 239000000203 mixture Substances 0.000 claims description 23
• 208000031226 Hyperlipidaemia Diseases 0.000 claims description 16
• SEERZIQQUAZTOL-ANMDKAQQSA-N cerivastatin Chemical compound COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 SEERZIQQUAZTOL-ANMDKAQQSA-N 0.000 claims description 16
• 229960005110 cerivastatin Drugs 0.000 claims description 16
• 241000124008 Mammalia Species 0.000 claims description 15
• PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims description 15
• RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 claims description 15
• 125000003118 aryl group Chemical group 0.000 claims description 15
• PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims description 15
• 229960004844 lovastatin Drugs 0.000 claims description 15
• QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 claims description 15
• TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 claims description 15
• 229960002855 simvastatin Drugs 0.000 claims description 15
• TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 claims description 14
• 229960002965 pravastatin Drugs 0.000 claims description 14
• 239000003085 diluting agent Substances 0.000 claims description 13
• 229960003765 fluvastatin Drugs 0.000 claims description 13
• 229950009116 mevastatin Drugs 0.000 claims description 13
• VDSBXXDKCUBMQC-HNGSOEQISA-N (4r,6s)-6-[(e)-2-[2-(4-fluoro-3-methylphenyl)-4,4,6,6-tetramethylcyclohexen-1-yl]ethenyl]-4-hydroxyoxan-2-one Chemical compound C1=C(F)C(C)=CC(C=2CC(C)(C)CC(C)(C)C=2\C=C\[C@H]2OC(=O)C[C@H](O)C2)=C1 VDSBXXDKCUBMQC-HNGSOEQISA-N 0.000 claims description 12
• 229950003040 dalvastatin Drugs 0.000 claims description 12
• 125000001072 heteroaryl group Chemical group 0.000 claims description 12
• 239000003937 drug carrier Substances 0.000 claims description 11
• 230000000694 effects Effects 0.000 claims description 11
• XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 claims description 10
• XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 claims description 10
• VGMFHMLQOYWYHN-UHFFFAOYSA-N Compactin Natural products OCC1OC(OC2C(O)C(O)C(CO)OC2Oc3cc(O)c4C(=O)C(=COc4c3)c5ccc(O)c(O)c5)C(O)C(O)C1O VGMFHMLQOYWYHN-UHFFFAOYSA-N 0.000 claims description 10
• 229960005370 atorvastatin Drugs 0.000 claims description 10
• GPUADMRJQVPIAS-QCVDVZFFSA-M cerivastatin sodium Chemical compound [Na+].COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 GPUADMRJQVPIAS-QCVDVZFFSA-M 0.000 claims description 10
• 206010002383 Angina Pectoris Diseases 0.000 claims description 9
• 230000000747 cardiac effect Effects 0.000 claims description 9
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 9
• 230000001225 therapeutic effect Effects 0.000 claims description 9
• OJRHUICOVVSGSY-RXMQYKEDSA-N (2s)-2-chloro-3-methylbutan-1-ol Chemical compound CC(C)[C@H](Cl)CO OJRHUICOVVSGSY-RXMQYKEDSA-N 0.000 claims description 7
• 229960001770 atorvastatin calcium Drugs 0.000 claims description 7
• GJOCABIDMCKCEG-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-3-methylbutanoic acid Chemical compound C1=CC(S(=O)(=O)NC(C(C)C)C(O)=O)=CC=C1C1=CC=C(Br)C=C1 GJOCABIDMCKCEG-UHFFFAOYSA-N 0.000 claims description 6
• 229940124530 sulfonamide Drugs 0.000 claims description 6
• 208000024891 symptom Diseases 0.000 claims description 6
• 125000003545 alkoxy group Chemical group 0.000 claims description 5
• 235000010290 biphenyl Nutrition 0.000 claims description 5
• 230000002411 adverse Effects 0.000 claims description 4
• 210000004351 coronary vessel Anatomy 0.000 claims description 4
• 239000002552 dosage form Substances 0.000 claims description 4
• 239000004305 biphenyl Substances 0.000 claims description 3
• 210000001715 carotid artery Anatomy 0.000 claims description 3
• 125000001424 substituent group Chemical group 0.000 claims description 3
• 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims description 2
• 150000002923 oximes Chemical class 0.000 claims description 2
• 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
• FJLGEFLZQAZZCD-JUFISIKESA-N (3S,5R)-fluvastatin Chemical compound C12=CC=CC=C2N(C(C)C)C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 FJLGEFLZQAZZCD-JUFISIKESA-N 0.000 claims 13
• 230000000055 hyoplipidemic effect Effects 0.000 claims 4
• 125000001475 halogen functional group Chemical group 0.000 claims 2
• 230000001747 exhibiting effect Effects 0.000 claims 1
• 230000002093 peripheral effect Effects 0.000 claims 1
• 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract description 52
• 208000019553 vascular disease Diseases 0.000 abstract description 11
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 159
• XSFAQQLHYUBFKV-UHFFFAOYSA-N 4-(4-phenylphenyl)butanoic acid Chemical compound C1=CC(CCCC(=O)O)=CC=C1C1=CC=CC=C1 XSFAQQLHYUBFKV-UHFFFAOYSA-N 0.000 description 132
• 150000001408 amides Chemical class 0.000 description 90
• 150000001875 compounds Chemical class 0.000 description 83
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 80
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 75
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 66
• 229960003136 leucine Drugs 0.000 description 60
• VPMJTASZJZRIMH-YFKPBYRVSA-N (2s)-n-methylpiperazine-2-carboxamide Chemical compound CNC(=O)[C@@H]1CNCCN1 VPMJTASZJZRIMH-YFKPBYRVSA-N 0.000 description 59
• 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 58
• 239000004395 L-leucine Substances 0.000 description 55
• MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 55
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 46
• 229910052739 hydrogen Inorganic materials 0.000 description 39
• 239000001257 hydrogen Substances 0.000 description 39
• 235000019454 L-leucine Nutrition 0.000 description 38
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 34
• JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 32
• 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 32
• 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 27
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 27
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 26
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 25
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 25
• WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 24
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 24
• GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 24
• FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 24
• 238000012360 testing method Methods 0.000 description 24
• 150000002431 hydrogen Chemical class 0.000 description 23
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 23
• BPKJNEIOHOEWLO-UHFFFAOYSA-N 2-amino-n,3,3-trimethylbutanamide Chemical compound CNC(=O)C(N)C(C)(C)C BPKJNEIOHOEWLO-UHFFFAOYSA-N 0.000 description 21
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 21
• AYORUWNJMKYNAD-JEDNCBNOSA-N 2-aminoacetic acid;(2s)-2-amino-4-methylpentanoic acid Chemical compound NCC(O)=O.CC(C)C[C@H](N)C(O)=O AYORUWNJMKYNAD-JEDNCBNOSA-N 0.000 description 18
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 17
• JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 16
• 239000003814 drug Substances 0.000 description 16
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 15
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 15
• BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 14
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 14
• 230000003902 lesion Effects 0.000 description 14
• VPMJTASZJZRIMH-UHFFFAOYSA-N n-methylpiperazine-2-carboxamide Chemical compound CNC(=O)C1CNCCN1 VPMJTASZJZRIMH-UHFFFAOYSA-N 0.000 description 14
• BVRKOQJETMBIDK-VIFPVBQESA-N (2s)-2-amino-n-methyl-3-phenylpropanamide Chemical compound CNC(=O)[C@@H](N)CC1=CC=CC=C1 BVRKOQJETMBIDK-VIFPVBQESA-N 0.000 description 13
• 239000004471 Glycine Substances 0.000 description 13
• 206010020772 Hypertension Diseases 0.000 description 13
• 229960004799 tryptophan Drugs 0.000 description 13
• 208000029078 coronary artery disease Diseases 0.000 description 12
• 239000012458 free base Substances 0.000 description 12
• YXVNFLKEYHOGTM-QRWMCTBCSA-N (7r)-9-(4-propylphenyl)nonane-1,5,7-tricarboxylic acid Chemical compound CCCC1=CC=C(CC[C@H](CC(CCCCC(O)=O)C(O)=O)C(O)=O)C=C1 YXVNFLKEYHOGTM-QRWMCTBCSA-N 0.000 description 11
• 229960003767 alanine Drugs 0.000 description 11
• 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 11
• 229940079593 drug Drugs 0.000 description 11
• 238000009472 formulation Methods 0.000 description 11
• 125000000446 sulfanediyl group Chemical group *S* 0.000 description 11
• 206010019280 Heart failures Diseases 0.000 description 10
• 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 10
• 150000002632 lipids Chemical class 0.000 description 10
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 9
• 208000024172 Cardiovascular disease Diseases 0.000 description 9
• 229910052736 halogen Inorganic materials 0.000 description 9
• 150000002367 halogens Chemical class 0.000 description 9
• ALBYIUDWACNRRB-UHFFFAOYSA-N hexanamide Chemical compound CCCCCC(N)=O ALBYIUDWACNRRB-UHFFFAOYSA-N 0.000 description 9
• ZWZUMHQJPFYTDW-CQSZACIVSA-N (2r)-2-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound CCCC1=CC=C(CC[C@H](CCC(O)=O)C(O)=O)C=C1 ZWZUMHQJPFYTDW-CQSZACIVSA-N 0.000 description 8
• SDCPDKWTXYZDGE-WPZCJLIBSA-N (4r)-2-methyl-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound CCCC1=CC=C(CC[C@H](CC(C)C(O)=O)C(O)=O)C=C1 SDCPDKWTXYZDGE-WPZCJLIBSA-N 0.000 description 8
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 8
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
• 235000012000 cholesterol Nutrition 0.000 description 8
• 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 8
• 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 8
• 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 8
• 229960005190 phenylalanine Drugs 0.000 description 8
• NPDBDJFLKKQMCM-UHFFFAOYSA-N tert-butylglycine Chemical compound CC(C)(C)C(N)C(O)=O NPDBDJFLKKQMCM-UHFFFAOYSA-N 0.000 description 8
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 7
• 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 7
• XOKVBTKTLBLNSW-UHFFFAOYSA-N 4-oxo-4-[4-(4-phenylpiperidin-1-yl)phenyl]butanoic acid Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 XOKVBTKTLBLNSW-UHFFFAOYSA-N 0.000 description 7
• 239000005711 Benzoic acid Substances 0.000 description 7
• 206010010904 Convulsion Diseases 0.000 description 7
• 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 7
• 210000001367 artery Anatomy 0.000 description 7
• 235000010233 benzoic acid Nutrition 0.000 description 7
• 229910002091 carbon monoxide Inorganic materials 0.000 description 7
• 235000005911 diet Nutrition 0.000 description 7
• 201000010099 disease Diseases 0.000 description 7
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 7
• 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 7
• 230000002265 prevention Effects 0.000 description 7
• 229910052717 sulfur Inorganic materials 0.000 description 7
• 125000000297 undecanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
• XRBKJPNGRGETAO-UHFFFAOYSA-N 2-amino-3,3-dimethyl-n-(2-phenylethyl)butanamide Chemical compound CC(C)(C)C(N)C(=O)NCCC1=CC=CC=C1 XRBKJPNGRGETAO-UHFFFAOYSA-N 0.000 description 6
• 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 6
• 108090000790 Enzymes Proteins 0.000 description 6
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 6
• 241001465754 Metazoa Species 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• 235000004279 alanine Nutrition 0.000 description 6
• MMCPOSDMTGQNKG-UHFFFAOYSA-N anilinium chloride Chemical compound Cl.NC1=CC=CC=C1 MMCPOSDMTGQNKG-UHFFFAOYSA-N 0.000 description 6
• 210000002376 aorta thoracic Anatomy 0.000 description 6
• 210000004369 blood Anatomy 0.000 description 6
• 239000008280 blood Substances 0.000 description 6
• 230000036772 blood pressure Effects 0.000 description 6
• 150000003857 carboxamides Chemical class 0.000 description 6
• 238000002586 coronary angiography Methods 0.000 description 6
• 238000011161 development Methods 0.000 description 6
• 229940088598 enzyme Drugs 0.000 description 6
• 125000004494 ethyl ester group Chemical group 0.000 description 6
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 6
• 210000002540 macrophage Anatomy 0.000 description 6
• 208000010125 myocardial infarction Diseases 0.000 description 6
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 6
• 125000006308 propyl amino group Chemical group 0.000 description 6
• HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 6
• ZQXYDSXOIXNPBN-VWLOTQADSA-N (2s)-3-phenyl-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]propanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCC(CC1)C=1C=CC=CC=1)C1=CC=CC=C1 ZQXYDSXOIXNPBN-VWLOTQADSA-N 0.000 description 5
• ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 description 5
• 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 5
• BYHDDXPKOZIZRV-UHFFFAOYSA-N 5-phenylpentanoic acid Chemical compound OC(=O)CCCCC1=CC=CC=C1 BYHDDXPKOZIZRV-UHFFFAOYSA-N 0.000 description 5
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
• 108010007622 LDL Lipoproteins Proteins 0.000 description 5
• 102000007330 LDL Lipoproteins Human genes 0.000 description 5
• 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 5
• 238000004458 analytical method Methods 0.000 description 5
• 125000006309 butyl amino group Chemical group 0.000 description 5
• 238000004364 calculation method Methods 0.000 description 5
• 125000004093 cyano group Chemical group *C#N 0.000 description 5
• 230000037213 diet Effects 0.000 description 5
• 125000005843 halogen group Chemical group 0.000 description 5
• 239000003112 inhibitor Substances 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 5
• 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 229960002429 proline Drugs 0.000 description 5
• 238000012216 screening Methods 0.000 description 5
• 239000000243 solution Substances 0.000 description 5
• 239000012453 solvate Substances 0.000 description 5
• 239000000758 substrate Substances 0.000 description 5
• 229940124597 therapeutic agent Drugs 0.000 description 5
• ZQXYDSXOIXNPBN-RUZDIDTESA-N (2r)-3-phenyl-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]propanoic acid Chemical compound C([C@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCC(CC1)C=1C=CC=CC=1)C1=CC=CC=C1 ZQXYDSXOIXNPBN-RUZDIDTESA-N 0.000 description 4
• HEABEIGWLYMIBY-JOCHJYFZSA-N (2r)-4-methyl-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]pentanoic acid Chemical compound C1=CC(S(=O)(=O)N[C@H](CC(C)C)C(O)=O)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 HEABEIGWLYMIBY-JOCHJYFZSA-N 0.000 description 4
• GJOCABIDMCKCEG-INIZCTEOSA-N (2s)-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-3-methylbutanoic acid Chemical compound C1=CC(S(=O)(=O)N[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=C(Br)C=C1 GJOCABIDMCKCEG-INIZCTEOSA-N 0.000 description 4
• ULOTXPTWJAUGGE-MHZLTWQESA-N (2s)-3-(1h-indol-3-yl)-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)S(=O)(=O)C(C=C1)=CC=C1N(CC1)CCC1C1=CC=CC=C1 ULOTXPTWJAUGGE-MHZLTWQESA-N 0.000 description 4
• HEABEIGWLYMIBY-QFIPXVFZSA-N (2s)-4-methyl-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]pentanoic acid Chemical compound C1=CC(S(=O)(=O)N[C@@H](CC(C)C)C(O)=O)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 HEABEIGWLYMIBY-QFIPXVFZSA-N 0.000 description 4
• IVNJKQPHHPMONX-WCCKRBBISA-N 2-aminoacetic acid;(2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N IVNJKQPHHPMONX-WCCKRBBISA-N 0.000 description 4
• 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 description 4
• 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 4
• OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 4
• 102100026802 72 kDa type IV collagenase Human genes 0.000 description 4
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
• 229930182821 L-proline Natural products 0.000 description 4
• 108010028554 LDL Cholesterol Proteins 0.000 description 4
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
• SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 4
• 239000000006 Nitroglycerin Substances 0.000 description 4
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
• 102100030416 Stromelysin-1 Human genes 0.000 description 4
• AXJDEHNQPMZKOS-UHFFFAOYSA-N acetylazanium;chloride Chemical compound [Cl-].CC([NH3+])=O AXJDEHNQPMZKOS-UHFFFAOYSA-N 0.000 description 4
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
• 150000002148 esters Chemical class 0.000 description 4
• 229960003711 glyceryl trinitrate Drugs 0.000 description 4
• 208000019622 heart disease Diseases 0.000 description 4
• 150000004677 hydrates Chemical class 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 4
• 230000010412 perfusion Effects 0.000 description 4
• 239000000902 placebo Substances 0.000 description 4
• 229940068196 placebo Drugs 0.000 description 4
• 150000003456 sulfonamides Chemical class 0.000 description 4
• BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 4
• 238000002604 ultrasonography Methods 0.000 description 4
• NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
• 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
• DVIKVXSMRJYYDK-SFHVURJKSA-N (2S)-2-(dibenzofuran-2-ylsulfonylamino)-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=C2C3=CC=CC=C3OC2=CC=1)C1=CC=CC=C1 DVIKVXSMRJYYDK-SFHVURJKSA-N 0.000 description 3
• AMZYGAHWDZJLAN-HNNXBMFYSA-N (2S)-2-(dibenzofuran-2-ylsulfonylamino)-4-methylpentanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)N[C@@H](CC(C)C)C(O)=O)=CC=C3OC2=C1 AMZYGAHWDZJLAN-HNNXBMFYSA-N 0.000 description 3
• YGNCGRVNRKDKCS-INIZCTEOSA-N (2s)-2-(dibenzofuran-2-ylsulfonylamino)-3-methylbutanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)N[C@@H](C(C)C)C(O)=O)=CC=C3OC2=C1 YGNCGRVNRKDKCS-INIZCTEOSA-N 0.000 description 3
• YPOJAHGDLHWILP-IBGZPJMESA-N (2s)-2-(dibenzofuran-2-ylsulfonylamino)-4-phenylbutanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=C2C3=CC=CC=C3OC2=CC=1)CC1=CC=CC=C1 YPOJAHGDLHWILP-IBGZPJMESA-N 0.000 description 3
• DIMHQAITVXMHMQ-SANMLTNESA-N (2s)-2-[[4-(4-benzylpiperidin-1-yl)phenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCC(CC=2C=CC=CC=2)CC1)C1=CC=CC=C1 DIMHQAITVXMHMQ-SANMLTNESA-N 0.000 description 3
• PGXLAZACGSXLAI-VWLOTQADSA-N (2s)-2-[[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(=CC=2)S(=O)(=O)N[C@@H](CC=2C=CC=CC=2)C(O)=O)CC1 PGXLAZACGSXLAI-VWLOTQADSA-N 0.000 description 3
• AWTBTVNHZFPSBT-AWEZNQCLSA-N (2s)-2-acetamido-4-dibenzofuran-2-yl-4-oxobutanoic acid Chemical compound C1=CC=C2C3=CC(C(=O)C[C@H](NC(=O)C)C(O)=O)=CC=C3OC2=C1 AWTBTVNHZFPSBT-AWEZNQCLSA-N 0.000 description 3
• DCXSZYLYDZGFMN-LBPRGKRZSA-N (2s)-2-amino-4-dibenzofuran-2-yl-4-oxobutanoic acid Chemical compound C1=CC=C2C3=CC(C(=O)C[C@H](N)C(O)=O)=CC=C3OC2=C1 DCXSZYLYDZGFMN-LBPRGKRZSA-N 0.000 description 3
• ZHMTXQMPTXZPIY-QHCPKHFHSA-N (2s)-4-dibenzofuran-2-yl-2-(dodecanoylamino)-4-oxobutanoic acid Chemical compound C1=CC=C2C3=CC(C(=O)C[C@H](NC(=O)CCCCCCCCCCC)C(O)=O)=CC=C3OC2=C1 ZHMTXQMPTXZPIY-QHCPKHFHSA-N 0.000 description 3
• LWMATGKIVQPBTO-FQEVSTJZSA-N (2s)-4-dibenzofuran-2-yl-4-oxo-2-(3-phenylpropanoylamino)butanoic acid Chemical compound N([C@@H](CC(=O)C=1C=C2C3=CC=CC=C3OC2=CC=1)C(=O)O)C(=O)CCC1=CC=CC=C1 LWMATGKIVQPBTO-FQEVSTJZSA-N 0.000 description 3
• NUZCSVKFVKXZEM-LBPRGKRZSA-N (2s)-4-dibenzofuran-2-yl-4-oxo-2-[(2,2,2-trifluoroacetyl)amino]butanoic acid Chemical compound C1=CC=C2C3=CC(C(=O)C[C@@H](C(=O)O)NC(=O)C(F)(F)F)=CC=C3OC2=C1 NUZCSVKFVKXZEM-LBPRGKRZSA-N 0.000 description 3
• LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 3
• QDFHMGIGICIHTR-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(2-pyridin-3-ylacetyl)amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CC1=CC=CN=C1 QDFHMGIGICIHTR-UHFFFAOYSA-N 0.000 description 3
• OMQQHSLJJQYZAN-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[3-(3,4-dimethoxyphenyl)propanoylamino]hexanoic acid Chemical compound C1=C(OC)C(OC)=CC=C1CCC(=O)NCCCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=2C=CC(Br)=CC=2)C=C1 OMQQHSLJJQYZAN-UHFFFAOYSA-N 0.000 description 3
• AFFUQTQAJDIUKC-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[3-(4-methoxyphenyl)propanoylamino]hexanoic acid Chemical compound C1=CC(OC)=CC=C1CCC(=O)NCCCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=2C=CC(Br)=CC=2)C=C1 AFFUQTQAJDIUKC-UHFFFAOYSA-N 0.000 description 3
• BAYMWVAVTBHBAI-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[4-(4-chloro-3-methylphenoxy)butanoylamino]hexanoic acid Chemical compound C1=C(Cl)C(C)=CC(OCCCC(=O)NCCCCC(NS(=O)(=O)C=2C=CC(=CC=2)C=2C=CC(Br)=CC=2)C(O)=O)=C1 BAYMWVAVTBHBAI-UHFFFAOYSA-N 0.000 description 3
• YCJXGDWGYODKOA-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2-(4-methoxyphenoxy)acetyl]amino]hexanoic acid Chemical compound C1=CC(OC)=CC=C1OCC(=O)NCCCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=2C=CC(Br)=CC=2)C=C1 YCJXGDWGYODKOA-UHFFFAOYSA-N 0.000 description 3
• NZZDABAGUVZGON-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2-(4-tert-butylphenoxy)acetyl]amino]hexanoic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1OCC(=O)NCCCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=2C=CC(Br)=CC=2)C=C1 NZZDABAGUVZGON-UHFFFAOYSA-N 0.000 description 3
• NMBNLIBIDNBQFI-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2-(cyclopenten-1-yl)acetyl]amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CC1=CCCC1 NMBNLIBIDNBQFI-UHFFFAOYSA-N 0.000 description 3
• ORQXBVXKBGUSBA-UHFFFAOYSA-N 2-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)C(N)CC1CCCCC1 ORQXBVXKBGUSBA-UHFFFAOYSA-N 0.000 description 3
• SBXDENYROQKXBE-UHFFFAOYSA-N 2-phenylbenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1C1=CC=CC=C1 SBXDENYROQKXBE-UHFFFAOYSA-N 0.000 description 3
• KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 3
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 3
• GIMDYSWWMCJCFQ-UHFFFAOYSA-N 4-[4-(4-bromophenyl)phenyl]-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NO)=CC=C1C1=CC=C(Br)C=C1 GIMDYSWWMCJCFQ-UHFFFAOYSA-N 0.000 description 3
• YAOAAQZCOAUNAE-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-4-(dimethylhydrazinylidene)butanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NN(C)C)=CC=C1C1=CC=C(Cl)C=C1 YAOAAQZCOAUNAE-UHFFFAOYSA-N 0.000 description 3
• IYWKVPQGIPOZMN-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-4-hydroxybutanoic acid Chemical compound C1=CC(C(CCC(O)=O)O)=CC=C1C1=CC=C(Cl)C=C1 IYWKVPQGIPOZMN-UHFFFAOYSA-N 0.000 description 3
• RQJMLGGTENDEFM-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NO)=CC=C1C1=CC=C(Cl)C=C1 RQJMLGGTENDEFM-UHFFFAOYSA-N 0.000 description 3
• 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 3
• KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 3
• WQIRLJOPXYUOCI-UHFFFAOYSA-N 6-[[2-(1,3-benzodioxol-5-yl)acetyl]amino]-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]hexanoic acid Chemical compound C=1C=C2OCOC2=CC=1CC(=O)NCCCCC(C(=O)O)NS(=O)(=O)C(C=C1)=CC=C1C1=CC=C(Br)C=C1 WQIRLJOPXYUOCI-UHFFFAOYSA-N 0.000 description 3
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 3
• PHIHZXSUZAJEII-SEEARECTSA-N CC1CCC2[C@@](C1)(C2(C)C)C(=O)N3CCCCN3NC Chemical compound CC1CCC2[C@@](C1)(C2(C)C)C(=O)N3CCCCN3NC PHIHZXSUZAJEII-SEEARECTSA-N 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
• 108010010234 HDL Lipoproteins Proteins 0.000 description 3
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
• 102100030417 Matrilysin Human genes 0.000 description 3
• 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 3
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• GNSLACGSDSJAIQ-UHFFFAOYSA-N [4-(4-phenyl-piperidin-1-yl)-benzenesulfonylamino]-acetic acid Chemical compound C1=CC(S(=O)(=O)NCC(=O)O)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 GNSLACGSDSJAIQ-UHFFFAOYSA-N 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 239000002220 antihypertensive agent Substances 0.000 description 3
• 239000003524 antilipemic agent Substances 0.000 description 3
• 239000007864 aqueous solution Substances 0.000 description 3
• JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 3
• 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 3
• SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 description 3
• 238000009554 carotid ultrasonography Methods 0.000 description 3
• 210000002808 connective tissue Anatomy 0.000 description 3
• PYRZPBDTPRQYKG-UHFFFAOYSA-N cyclopentene-1-carboxylic acid Chemical compound OC(=O)C1=CCCC1 PYRZPBDTPRQYKG-UHFFFAOYSA-N 0.000 description 3
• 230000008030 elimination Effects 0.000 description 3
• 238000003379 elimination reaction Methods 0.000 description 3
• 238000011156 evaluation Methods 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 150000002596 lactones Chemical group 0.000 description 3
• OCSMOTCMPXTDND-OUAUKWLOSA-N marimastat Chemical compound CNC(=O)[C@H](C(C)(C)C)NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO OCSMOTCMPXTDND-OUAUKWLOSA-N 0.000 description 3
• 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 3
• 150000004702 methyl esters Chemical class 0.000 description 3
• 238000012544 monitoring process Methods 0.000 description 3
• BSIZUMJRKYHEBR-QGZVFWFLSA-N n-hydroxy-2(r)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N([C@H](C(C)C)C(=O)NO)CC1=CC=CN=C1 BSIZUMJRKYHEBR-QGZVFWFLSA-N 0.000 description 3
• XTZSTNYJRISMQA-UHFFFAOYSA-N n-hydroxy-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]acetamide Chemical compound C1=CC(S(=O)(=O)NCC(=O)NO)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 XTZSTNYJRISMQA-UHFFFAOYSA-N 0.000 description 3
• 150000002823 nitrates Chemical class 0.000 description 3
• 229910052757 nitrogen Inorganic materials 0.000 description 3
• 229960001639 penicillamine Drugs 0.000 description 3
• ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 3
• 125000005328 phosphinyl group Chemical group [PH2](=O)* 0.000 description 3
• 238000002600 positron emission tomography Methods 0.000 description 3
• 108090000765 processed proteins & peptides Proteins 0.000 description 3
• 239000011734 sodium Substances 0.000 description 3
• 229940083542 sodium Drugs 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
• REKHMRWKZZYTDP-KLLZUTDZSA-N (2S)-2-(dibenzofuran-2-ylsulfonylamino)-3-methylpentanoic acid Chemical compound C1=C(C=CC=2OC3=C(C=21)C=CC=C3)S(=O)(=O)N[C@H](C(=O)O)C(CC)C REKHMRWKZZYTDP-KLLZUTDZSA-N 0.000 description 2
• LSKVCOMPLXHQRD-KLLZUTDZSA-N (2S)-2-(dibenzofuran-2-ylsulfonylamino)-N-hydroxy-3-methylpentanamide Chemical compound ONC([C@H](C(CC)C)NS(=O)(=O)C1=CC2=C(OC3=C2C=CC=C3)C=C1)=O LSKVCOMPLXHQRD-KLLZUTDZSA-N 0.000 description 2
• KLJMAQDORBAMIU-LBPRGKRZSA-N (2S)-2-(dibenzofuran-2-ylsulfonylamino)butanedioic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)N[C@@H](CC(=O)O)C(O)=O)=CC=C3OC2=C1 KLJMAQDORBAMIU-LBPRGKRZSA-N 0.000 description 2
• ZIKZEEKTVYFKKF-VIFPVBQESA-N (2S)-2-(dibenzofuran-2-ylsulfonylamino)propanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)N[C@@H](C)C(O)=O)=CC=C3OC2=C1 ZIKZEEKTVYFKKF-VIFPVBQESA-N 0.000 description 2
• YDGXLVKDGGLWPF-SCSAIBSYSA-N (2r)-1,3-thiazolidine-2-carboxamide Chemical compound NC(=O)[C@@H]1NCCS1 YDGXLVKDGGLWPF-SCSAIBSYSA-N 0.000 description 2
• CCLNNAZFIAEPBM-IBGZPJMESA-N (2r)-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]-3-sulfanylpropanoic acid Chemical compound C1=CC(S(=O)(=O)N[C@@H](CS)C(=O)O)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 CCLNNAZFIAEPBM-IBGZPJMESA-N 0.000 description 2
• XHTVHWPJPDRGQI-QNGWXLTQSA-N (2r)-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]-3-tritylsulfanylpropanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCC(CC1)C=1C=CC=CC=1)SC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 XHTVHWPJPDRGQI-QNGWXLTQSA-N 0.000 description 2
• ULOTXPTWJAUGGE-HHHXNRCGSA-N (2r)-3-(1h-indol-3-yl)-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]propanoic acid Chemical compound N([C@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)S(=O)(=O)C(C=C1)=CC=C1N(CC1)CCC1C1=CC=CC=C1 ULOTXPTWJAUGGE-HHHXNRCGSA-N 0.000 description 2
• NUZCSVKFVKXZEM-GFCCVEGCSA-N (2r)-4-dibenzofuran-2-yl-4-oxo-2-[(2,2,2-trifluoroacetyl)amino]butanoic acid Chemical compound C1=CC=C2C3=CC(C(=O)C[C@H](C(=O)O)NC(=O)C(F)(F)F)=CC=C3OC2=C1 NUZCSVKFVKXZEM-GFCCVEGCSA-N 0.000 description 2
• ADRXVXDGDFNWTL-JIDHJSLPSA-N (2s)-2-[[4-[4-(3-hydroxyphenyl)piperazin-1-yl]phenyl]sulfonylamino]-3-phenylpropanoic acid;hydrobromide Chemical compound Br.C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCN(CC1)C=1C=C(O)C=CC=1)C1=CC=CC=C1 ADRXVXDGDFNWTL-JIDHJSLPSA-N 0.000 description 2
• WKLSCPMFMSEKHJ-VWLOTQADSA-N (2s)-2-[[4-[4-(3-methoxyphenyl)piperazin-1-yl]phenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound COC1=CC=CC(N2CCN(CC2)C=2C=CC(=CC=2)S(=O)(=O)N[C@@H](CC=2C=CC=CC=2)C(O)=O)=C1 WKLSCPMFMSEKHJ-VWLOTQADSA-N 0.000 description 2
• HTOYWGIWQZQPSR-DEOSSOPVSA-N (2s)-2-[[4-[4-(4-chlorophenyl)piperazin-1-yl]phenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCN(CC1)C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 HTOYWGIWQZQPSR-DEOSSOPVSA-N 0.000 description 2
• PNCLRHJDVNOKGF-DEOSSOPVSA-N (2s)-2-[[4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCN(CC1)C=1C=CC(O)=CC=1)C1=CC=CC=C1 PNCLRHJDVNOKGF-DEOSSOPVSA-N 0.000 description 2
• TUTUNLNFCQXYEE-SFHVURJKSA-N (2s)-2-benzamido-4-dibenzofuran-2-yl-4-oxobutanoic acid Chemical compound N([C@@H](CC(=O)C=1C=C2C3=CC=CC=C3OC2=CC=1)C(=O)O)C(=O)C1=CC=CC=C1 TUTUNLNFCQXYEE-SFHVURJKSA-N 0.000 description 2
• NSACXBTYAXSYCE-VWLOTQADSA-N (2s)-3-(4-hydroxyphenyl)-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]propanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCC(CC1)C=1C=CC=CC=1)C1=CC=C(O)C=C1 NSACXBTYAXSYCE-VWLOTQADSA-N 0.000 description 2
• IPPBZBAQYUONQO-YTTGMZPUSA-N (2s)-3-(4-phenylmethoxyphenyl)-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]propanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCC(CC1)C=1C=CC=CC=1)C(C=C1)=CC=C1OCC1=CC=CC=C1 IPPBZBAQYUONQO-YTTGMZPUSA-N 0.000 description 2
• UBSXVJZNZIPKCM-DEOSSOPVSA-N (2s)-3-phenyl-2-[[4-(4-phenylpiperazin-1-yl)phenyl]sulfonylamino]propanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCN(CC1)C=1C=CC=CC=1)C1=CC=CC=C1 UBSXVJZNZIPKCM-DEOSSOPVSA-N 0.000 description 2
• LHSUGDCTBKCBMN-QHCPKHFHSA-N (2s)-4-dibenzofuran-2-yl-2-[[2,6-di(propan-2-yl)phenyl]carbamoylamino]-4-oxobutanoic acid Chemical compound CC(C)C1=CC=CC(C(C)C)=C1NC(=O)N[C@H](C(O)=O)CC(=O)C1=CC=C(OC=2C3=CC=CC=2)C3=C1 LHSUGDCTBKCBMN-QHCPKHFHSA-N 0.000 description 2
• BBIUWUFUMFZBLS-DEOSSOPVSA-N (2s)-4-dibenzofuran-2-yl-4-oxo-2-(7-phenylheptanoylamino)butanoic acid Chemical compound N([C@@H](CC(=O)C=1C=C2C3=CC=CC=C3OC2=CC=1)C(=O)O)C(=O)CCCCCCC1=CC=CC=C1 BBIUWUFUMFZBLS-DEOSSOPVSA-N 0.000 description 2
• NMCAXOLGEVSANY-IBGZPJMESA-N (2s)-4-dibenzofuran-2-yl-4-oxo-2-[(2-phenylacetyl)amino]butanoic acid Chemical compound N([C@@H](CC(=O)C=1C=C2C3=CC=CC=C3OC2=CC=1)C(=O)O)C(=O)CC1=CC=CC=C1 NMCAXOLGEVSANY-IBGZPJMESA-N 0.000 description 2
• DTTSJWNGBWEGJL-DEOSSOPVSA-N (2s)-4-dibenzofuran-2-yl-4-oxo-2-[(4-phenylbenzoyl)amino]butanoic acid Chemical compound N([C@@H](CC(=O)C=1C=C2C3=CC=CC=C3OC2=CC=1)C(=O)O)C(=O)C(C=C1)=CC=C1C1=CC=CC=C1 DTTSJWNGBWEGJL-DEOSSOPVSA-N 0.000 description 2
• SMCUDZWBQOPQEA-SANMLTNESA-N (2s)-4-phenyl-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]butanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)N1CCC(CC1)C=1C=CC=CC=1)CC1=CC=CC=C1 SMCUDZWBQOPQEA-SANMLTNESA-N 0.000 description 2
• CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 2
• ZGGHKIMDNBDHJB-RPQBTBOMSA-M (3S,5R)-fluvastatin sodium Chemical class [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@H](O)C[C@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-RPQBTBOMSA-M 0.000 description 2
• XDLSSXYTUMNOHY-AWEZNQCLSA-N (3s)-3-[(dibenzofuran-2-ylsulfonylamino)methyl]-5-methylhexanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)NC[C@@H](CC(C)C)CC(O)=O)=CC=C3OC2=C1 XDLSSXYTUMNOHY-AWEZNQCLSA-N 0.000 description 2
• LNGVLSZEFFMWIU-OHYPFYFLSA-N (4z)-4-phenylmethoxyimino-4-[4-(4-phenylpiperidin-1-yl)phenyl]butanoic acid Chemical compound C=1C=C(N2CCC(CC2)C=2C=CC=CC=2)C=CC=1C(/CCC(=O)O)=N\OCC1=CC=CC=C1 LNGVLSZEFFMWIU-OHYPFYFLSA-N 0.000 description 2
• UGRMITBWUVWUEB-UHFFFAOYSA-N 1-$l^{1}-oxidanyl-3-methylbenzene Chemical group CC1=CC=CC([O])=C1 UGRMITBWUVWUEB-UHFFFAOYSA-N 0.000 description 2
• IDLCHIYQDJIYKY-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)acetic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)NCC(=O)O)=CC=C3OC2=C1 IDLCHIYQDJIYKY-UHFFFAOYSA-N 0.000 description 2
• SZUBKECHPDTJKS-UHFFFAOYSA-N 2-[(2-ethoxyphenyl)methyl-octylsulfonylamino]-n-hydroxyacetamide Chemical compound CCCCCCCCS(=O)(=O)N(CC(=O)NO)CC1=CC=CC=C1OCC SZUBKECHPDTJKS-UHFFFAOYSA-N 0.000 description 2
• HPNHKFGCOBDJOL-UHFFFAOYSA-N 2-[(4-chlorophenyl)methyl-octylsulfonylamino]-n-hydroxyacetamide Chemical compound CCCCCCCCS(=O)(=O)N(CC(=O)NO)CC1=CC=C(Cl)C=C1 HPNHKFGCOBDJOL-UHFFFAOYSA-N 0.000 description 2
• ONDHOCAWMCIXLR-UHFFFAOYSA-N 2-[2-[4-(4-chlorophenyl)phenyl]-2-hydroxyiminoethyl]-2-fluoro-5-phenylpentanoic acid Chemical compound C=1C=C(C=2C=CC(Cl)=CC=2)C=CC=1C(=NO)CC(F)(C(O)=O)CCCC1=CC=CC=C1 ONDHOCAWMCIXLR-UHFFFAOYSA-N 0.000 description 2
• ACTQLAONUVECDR-UHFFFAOYSA-N 2-[2-[4-(4-chlorophenyl)phenyl]-2-hydroxyiminoethyl]-2-fluoro-6-phenylhexanoic acid Chemical compound C=1C=C(C=2C=CC(Cl)=CC=2)C=CC=1C(=NO)CC(F)(C(O)=O)CCCCC1=CC=CC=C1 ACTQLAONUVECDR-UHFFFAOYSA-N 0.000 description 2
• LGJCTCXTISERQE-UHFFFAOYSA-N 2-[2-[4-(4-chlorophenyl)phenyl]-2-hydroxyiminoethyl]-5-(1,3-dioxoisoindol-2-yl)-2-fluoropentanoic acid Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCCC(F)(C(O)=O)CC(=NO)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1 LGJCTCXTISERQE-UHFFFAOYSA-N 0.000 description 2
• SFJBLNTZMZBRQC-UHFFFAOYSA-N 2-[2-[4-(4-chlorophenyl)phenyl]-2-hydroxyiminoethyl]-5-(n-ethylanilino)-2-fluoro-5-oxopentanoic acid Chemical compound C=1C=CC=CC=1N(CC)C(=O)CCC(F)(C(O)=O)CC(=NO)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1 SFJBLNTZMZBRQC-UHFFFAOYSA-N 0.000 description 2
• QIOYIGUCVWDDSG-UHFFFAOYSA-N 2-[2-[4-(4-chlorophenyl)phenyl]-2-hydroxyiminoethyl]-6-(1,3-dioxoisoindol-2-yl)-2-fluorohexanoic acid Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCCCC(F)(C(O)=O)CC(=NO)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1 QIOYIGUCVWDDSG-UHFFFAOYSA-N 0.000 description 2
• UXRQPYBOLVQYQD-UHFFFAOYSA-N 2-[2-methylpropyl-[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]acetic acid Chemical compound C1=CC(S(=O)(=O)N(CC(O)=O)CC(C)C)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 UXRQPYBOLVQYQD-UHFFFAOYSA-N 0.000 description 2
• OUNUWEGDJDDKQT-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(2-naphthalen-1-yloxyacetyl)amino]hexanoic acid Chemical compound C=1C=CC2=CC=CC=C2C=1OCC(=O)NCCCCC(C(=O)O)NS(=O)(=O)C(C=C1)=CC=C1C1=CC=C(Br)C=C1 OUNUWEGDJDDKQT-UHFFFAOYSA-N 0.000 description 2
• DLOYPNWOLLZVLA-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(2-pyridin-2-ylacetyl)amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CC1=CC=CC=N1 DLOYPNWOLLZVLA-UHFFFAOYSA-N 0.000 description 2
• KCAUFUXREROFOX-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2-(4-nitrophenoxy)acetyl]amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)COC1=CC=C([N+]([O-])=O)C=C1 KCAUFUXREROFOX-UHFFFAOYSA-N 0.000 description 2
• SQTBYARBJNHGQJ-UHFFFAOYSA-N 2-[[4-(4-phenylpiperazin-1-yl)phenyl]sulfonylamino]acetic acid Chemical compound C1=CC(S(=O)(=O)NCC(=O)O)=CC=C1N1CCN(C=2C=CC=CC=2)CC1 SQTBYARBJNHGQJ-UHFFFAOYSA-N 0.000 description 2
• ZEEYNQNRMIBLMK-DFWYDOINSA-N 2-aminoacetic acid;(2s)-2-aminopentanedioic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CCC(O)=O ZEEYNQNRMIBLMK-DFWYDOINSA-N 0.000 description 2
• SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 2
• NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 2
• 125000006304 2-iodophenyl group Chemical group [H]C1=C([H])C(I)=C(*)C([H])=C1[H] 0.000 description 2
• RDUOXXVFDHHAPP-UHFFFAOYSA-N 3-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]propanoic acid Chemical compound C1=CC(S(=O)(=O)NCCC(=O)O)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 RDUOXXVFDHHAPP-UHFFFAOYSA-N 0.000 description 2
• 102100029077 3-hydroxy-3-methylglutaryl-coenzyme A reductase Human genes 0.000 description 2
• 101710158485 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 description 2
• PKUGMMYQZAMIDX-UHFFFAOYSA-N 3-methyl-5-oxo-5-[4-(4-phenylpiperidin-1-yl)phenyl]pentanoic acid Chemical compound C1=CC(C(=O)CC(CC(O)=O)C)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 PKUGMMYQZAMIDX-UHFFFAOYSA-N 0.000 description 2
• ZYTOBAWIRVFDJA-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)phenyl]-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NO)=CC=C1C1=CC=C(Cl)C=C1Cl ZYTOBAWIRVFDJA-UHFFFAOYSA-N 0.000 description 2
• SIJLYWOEHFFLGG-UHFFFAOYSA-N 4-[4-(2,4-difluorophenyl)phenyl]-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NO)=CC=C1C1=CC=C(F)C=C1F SIJLYWOEHFFLGG-UHFFFAOYSA-N 0.000 description 2
• ZKAXZKMSZPJJAV-UHFFFAOYSA-N 4-[4-(4-bromo-2-fluorophenyl)phenyl]-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NO)=CC=C1C1=CC=C(Br)C=C1F ZKAXZKMSZPJJAV-UHFFFAOYSA-N 0.000 description 2
• RNOFOKVCZYVPMA-UHFFFAOYSA-N 4-[4-(4-chloro-2-fluorophenyl)phenyl]-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NO)=CC=C1C1=CC=C(Cl)C=C1F RNOFOKVCZYVPMA-UHFFFAOYSA-N 0.000 description 2
• IGXCIGJOOHSVAF-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-2,2,3,3-tetrafluoro-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(=NO)C(F)(F)C(F)(F)C(O)=O)=CC=C1C1=CC=C(Cl)C=C1 IGXCIGJOOHSVAF-UHFFFAOYSA-N 0.000 description 2
• ZVQAMRMZOISPNF-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-2,2-difluoro-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(CC(F)(F)C(O)=O)=NO)=CC=C1C1=CC=C(Cl)C=C1 ZVQAMRMZOISPNF-UHFFFAOYSA-N 0.000 description 2
• UTHIPJQXGSUBSL-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-2-[2-(1,3-dioxobenzo[f]isoindol-2-yl)ethyl]-2-fluoro-4-hydroxyiminobutanoic acid Chemical compound O=C1C2=CC3=CC=CC=C3C=C2C(=O)N1CCC(F)(C(O)=O)CC(=NO)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1 UTHIPJQXGSUBSL-UHFFFAOYSA-N 0.000 description 2
• ZJVVTRVFQVMDPY-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-2-fluoro-4-hydroxyimino-2-(1H-indol-3-yl)-3-methylbutanoic acid Chemical compound ClC1=CC=C(C=C1)C1=CC=C(C=C1)C(C(C(C(=O)O)(C1=CNC2=CC=CC=C12)F)C)=NO ZJVVTRVFQVMDPY-UHFFFAOYSA-N 0.000 description 2
• RIPBPXRFYMYPAE-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-2-fluoro-4-hydroxyimino-2-(2-phenylethyl)butanoic acid Chemical compound C=1C=C(C=2C=CC(Cl)=CC=2)C=CC=1C(=NO)CC(F)(C(O)=O)CCC1=CC=CC=C1 RIPBPXRFYMYPAE-UHFFFAOYSA-N 0.000 description 2
• KTCNKNZOAIHBRD-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-2-fluoro-4-hydroxyimino-2-(phenylsulfanylmethyl)butanoic acid Chemical compound C=1C=C(C=2C=CC(Cl)=CC=2)C=CC=1C(=NO)CC(F)(C(O)=O)CSC1=CC=CC=C1 KTCNKNZOAIHBRD-UHFFFAOYSA-N 0.000 description 2
• QLOVCQFIZUKWFR-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-2-fluoro-4-hydroxyimino-2-methylbutanoic acid Chemical compound C1=CC(C(=NO)CC(F)(C)C(O)=O)=CC=C1C1=CC=C(Cl)C=C1 QLOVCQFIZUKWFR-UHFFFAOYSA-N 0.000 description 2
• MZZSBYJTHHTGEM-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-2-fluoro-4-hydroxyimino-3,3-dimethylbutanoic acid Chemical compound C1=CC(C(=NO)C(C)(C(F)C(O)=O)C)=CC=C1C1=CC=C(Cl)C=C1 MZZSBYJTHHTGEM-UHFFFAOYSA-N 0.000 description 2
• IRBKJJBJLGTLKN-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-3,3-difluoro-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(=NO)C(F)(F)CC(O)=O)=CC=C1C1=CC=C(Cl)C=C1 IRBKJJBJLGTLKN-UHFFFAOYSA-N 0.000 description 2
• JFUAQBDWRURWGZ-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-3-fluoro-4-hydroxyimino-2,2-dimethylbutanoic acid Chemical compound C1=CC(C(=NO)C(F)C(C)(C)C(O)=O)=CC=C1C1=CC=C(Cl)C=C1 JFUAQBDWRURWGZ-UHFFFAOYSA-N 0.000 description 2
• UGTUJSZRMWTLES-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-3-fluoro-4-oxobutanoic acid Chemical compound C1=CC(C(=O)C(F)CC(=O)O)=CC=C1C1=CC=C(Cl)C=C1 UGTUJSZRMWTLES-UHFFFAOYSA-N 0.000 description 2
• JETIIFTUWCPZEG-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-4-methoxyiminobutanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NOC)=CC=C1C1=CC=C(Cl)C=C1 JETIIFTUWCPZEG-UHFFFAOYSA-N 0.000 description 2
• DXPWOIWQAFPUJZ-UHFFFAOYSA-N 4-[4-(4-fluorophenyl)phenyl]-4-hydroxyiminobutanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NO)=CC=C1C1=CC=C(F)C=C1 DXPWOIWQAFPUJZ-UHFFFAOYSA-N 0.000 description 2
• NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 2
• NTPKBGKSVCBASL-UHFFFAOYSA-N 4-hydroxyimino-4-[4-[4-(trifluoromethyl)phenyl]phenyl]butanoic acid Chemical compound C1=CC(C(CCC(O)=O)=NO)=CC=C1C1=CC=C(C(F)(F)F)C=C1 NTPKBGKSVCBASL-UHFFFAOYSA-N 0.000 description 2
• 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 2
• SGJNBMOXAMANCI-UHFFFAOYSA-N 4-oxo-4-[4-(4-phenylpiperazin-1-yl)phenyl]butanoic acid Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1N1CCN(C=2C=CC=CC=2)CC1 SGJNBMOXAMANCI-UHFFFAOYSA-N 0.000 description 2
• YIBZPVVKWIHFLM-UHFFFAOYSA-N 5-phenyl-2-[[4-(4-phenylpiperidin-1-yl)phenyl]sulfonylamino]pentanoic acid Chemical compound C=1C=C(N2CCC(CC2)C=2C=CC=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCC1=CC=CC=C1 YIBZPVVKWIHFLM-UHFFFAOYSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
• QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
• ICMAFTSLXCXHRK-UHFFFAOYSA-N Ethyl pentanoate Chemical compound CCCCC(=O)OCC ICMAFTSLXCXHRK-UHFFFAOYSA-N 0.000 description 2
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 108010026132 Gelatinases Proteins 0.000 description 2
• 102000013382 Gelatinases Human genes 0.000 description 2
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
• 101000627872 Homo sapiens 72 kDa type IV collagenase Proteins 0.000 description 2
• 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 2
• 101000990912 Homo sapiens Matrilysin Proteins 0.000 description 2
• 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 description 2
• 101000990915 Homo sapiens Stromelysin-1 Proteins 0.000 description 2
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
• 235000014852 L-arginine Nutrition 0.000 description 2
• 229930064664 L-arginine Natural products 0.000 description 2
• 238000008214 LDL Cholesterol Methods 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 102000000422 Matrix Metalloproteinase 3 Human genes 0.000 description 2
• 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 2
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
• QPYYMFJNZAEBJP-XDOYNYLZSA-N O\N=C(\CCC(=O)O)/C1=CC=C(C=C1)N1CCC(CC1)C1=CC=CC=C1 Chemical compound O\N=C(\CCC(=O)O)/C1=CC=C(C=C1)N1CCC(CC1)C1=CC=CC=C1 QPYYMFJNZAEBJP-XDOYNYLZSA-N 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 208000031481 Pathologic Constriction Diseases 0.000 description 2
• 235000019483 Peanut oil Nutrition 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 2
• WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 208000006011 Stroke Diseases 0.000 description 2
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
• 208000007536 Thrombosis Diseases 0.000 description 2
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
• DSFVQIUBODXRLL-UHFFFAOYSA-N acetamide;dihydrochloride Chemical compound Cl.Cl.CC(N)=O DSFVQIUBODXRLL-UHFFFAOYSA-N 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 2
• 238000002583 angiography Methods 0.000 description 2
• 238000002399 angioplasty Methods 0.000 description 2
• 230000003276 anti-hypertensive effect Effects 0.000 description 2
• 239000003529 anticholesteremic agent Substances 0.000 description 2
• 229940127226 anticholesterol agent Drugs 0.000 description 2
• 210000001765 aortic valve Anatomy 0.000 description 2
• 125000003710 aryl alkyl group Chemical group 0.000 description 2
• 230000003143 atherosclerotic effect Effects 0.000 description 2
• 239000002585 base Substances 0.000 description 2
• XFILPEOLDIKJHX-QYZOEREBSA-N batimastat Chemical compound C([C@@H](C(=O)NC)NC(=O)[C@H](CC(C)C)[C@H](CSC=1SC=CC=1)C(=O)NO)C1=CC=CC=C1 XFILPEOLDIKJHX-QYZOEREBSA-N 0.000 description 2
• WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
• UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
• 229940000635 beta-alanine Drugs 0.000 description 2
• 210000004204 blood vessel Anatomy 0.000 description 2
• RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 2
• 150000004648 butanoic acid derivatives Chemical class 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
• 229960001231 choline Drugs 0.000 description 2
• 238000013270 controlled release Methods 0.000 description 2
• 239000006184 cosolvent Substances 0.000 description 2
• LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 2
• 125000000753 cycloalkyl group Chemical group 0.000 description 2
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 206010012601 diabetes mellitus Diseases 0.000 description 2
• 230000035487 diastolic blood pressure Effects 0.000 description 2
• TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 2
• 230000000378 dietary effect Effects 0.000 description 2
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
• 229940043237 diethanolamine Drugs 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 2
• 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
• ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 2
• NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
• 229910052731 fluorine Inorganic materials 0.000 description 2
• 239000011737 fluorine Substances 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 230000003301 hydrolyzing effect Effects 0.000 description 2
• 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 2
• 208000028867 ischemia Diseases 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 150000004682 monohydrates Chemical class 0.000 description 2
• 230000002107 myocardial effect Effects 0.000 description 2
• RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 2
• DKGQJJYMQYEUDM-UHFFFAOYSA-N n-hydroxy-2-[naphthalen-2-ylmethyl(octylsulfonyl)amino]acetamide Chemical compound C1=CC=CC2=CC(CN(CC(=O)NO)S(=O)(=O)CCCCCCCC)=CC=C21 DKGQJJYMQYEUDM-UHFFFAOYSA-N 0.000 description 2
• BNOGOCHBBWMPKH-UHFFFAOYSA-N n-hydroxy-4-oxo-4-[4-(4-phenylpiperidin-1-yl)phenyl]butanamide Chemical compound C1=CC(C(=O)CCC(=O)NO)=CC=C1N1CCC(C=2C=CC=CC=2)CC1 BNOGOCHBBWMPKH-UHFFFAOYSA-N 0.000 description 2
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 239000012188 paraffin wax Substances 0.000 description 2
• 239000000312 peanut oil Substances 0.000 description 2
• IPWFJLQDVFKJDU-UHFFFAOYSA-N pentanamide Chemical compound CCCCC(N)=O IPWFJLQDVFKJDU-UHFFFAOYSA-N 0.000 description 2
• 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
• 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
• 229960005141 piperazine Drugs 0.000 description 2
• XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
• 102000004196 processed proteins & peptides Human genes 0.000 description 2
• 239000000651 prodrug Substances 0.000 description 2
• 229940002612 prodrug Drugs 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 235000019260 propionic acid Nutrition 0.000 description 2
• HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 description 2
• OAWXZFGKDDFTGS-UHFFFAOYSA-N pyrrolidine-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCN1C(O)=O OAWXZFGKDDFTGS-UHFFFAOYSA-N 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
• 208000037803 restenosis Diseases 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 208000037804 stenosis Diseases 0.000 description 2
• 230000036262 stenosis Effects 0.000 description 2
• 108091007196 stromelysin Proteins 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
• KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
• UIUJIQZEACWQSV-UHFFFAOYSA-N succinic semialdehyde Chemical compound OC(=O)CCC=O UIUJIQZEACWQSV-UHFFFAOYSA-N 0.000 description 2
• 229910021653 sulphate ion Inorganic materials 0.000 description 2
• 210000001519 tissue Anatomy 0.000 description 2
• UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
• 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
• 229960000281 trometamol Drugs 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• RPPLGDIQVLYEKH-QGZVFWFLSA-N (2R)-N-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-N-methylbutanamide Chemical compound CC[C@H](C(=O)N(C)O)N(CC1=CN=CC=C1)S(=O)(=O)C2=CC=C(C=C2)OC RPPLGDIQVLYEKH-QGZVFWFLSA-N 0.000 description 1
• TWIMRMWVRSEUBC-IXLXJOPFSA-N (2S)-2-[3-(benzenesulfonyl)propyl]-5-[(3S,4R)-1-[2-[2-(1H-imidazol-5-yl)phenyl]ethyl]-3-(methylcarbamoyl)diazinan-4-yl]-5-oxopentanoic acid Chemical compound N1C=NC(=C1)C1=C(C=CC=C1)CCN1N[C@@H]([C@@H](CC1)C(CC[C@H](C(=O)O)CCCS(=O)(=O)C1=CC=CC=C1)=O)C(=O)NC TWIMRMWVRSEUBC-IXLXJOPFSA-N 0.000 description 1
• AMIUQCXUAHBZJT-WBJKNQCFSA-N (2S)-2-[3-(benzenesulfonyl)propyl]-5-[(3S,4R)-1-[2-[4-[(dimethylamino)methyl]phenyl]ethyl]-3-(methylcarbamoyl)diazinan-4-yl]-5-oxopentanoic acid Chemical compound CN(C)CC1=CC=C(C=C1)CCN1N[C@@H]([C@@H](CC1)C(CC[C@H](C(=O)O)CCCS(=O)(=O)C1=CC=CC=C1)=O)C(=O)NC AMIUQCXUAHBZJT-WBJKNQCFSA-N 0.000 description 1
• FLOUJQGELDZGAD-IXLXJOPFSA-N (2S)-2-[3-(benzenesulfonyl)propyl]-5-[(3S,4R)-3-(methylcarbamoyl)-1-[2-[2-(1,3-oxazol-4-yl)phenyl]ethyl]diazinan-4-yl]-5-oxopentanoic acid Chemical compound O1C=NC(=C1)C1=C(C=CC=C1)CCN1N[C@@H]([C@@H](CC1)C(CC[C@H](C(=O)O)CCCS(=O)(=O)C1=CC=CC=C1)=O)C(=O)NC FLOUJQGELDZGAD-IXLXJOPFSA-N 0.000 description 1
• QWZQJTVPOJJYFH-IXLXJOPFSA-N (2S)-2-[3-(benzenesulfonyl)propyl]-5-[(3S,4R)-3-(methylcarbamoyl)-1-[2-[2-(1,3-thiazol-4-yl)phenyl]ethyl]diazinan-4-yl]-5-oxopentanoic acid Chemical compound S1C=NC(=C1)C1=C(C=CC=C1)CCN1N[C@@H]([C@@H](CC1)C(CC[C@H](C(=O)O)CCCS(=O)(=O)C1=CC=CC=C1)=O)C(=O)NC QWZQJTVPOJJYFH-IXLXJOPFSA-N 0.000 description 1
• HMPZLFNSHKNTNU-PKDNWHCCSA-N (2S)-2-amino-6-[4-(hydroxyamino)-4-oxobutan-2-yl]sulfanyl-2-[(4-methoxyphenyl)methyl]-N-methylhexanamide Chemical compound ONC(=O)CC(C)SCCCC[C@@](N)(C(=O)NC)CC1=CC=C(OC)C=C1 HMPZLFNSHKNTNU-PKDNWHCCSA-N 0.000 description 1
• LQXWOHATGIQWTF-WPZCJLIBSA-N (2r)-2-[2-(4-propylphenyl)propyl]pentanedioic acid Chemical compound CCCC1=CC=C(C(C)C[C@@H](CCC(O)=O)C(O)=O)C=C1 LQXWOHATGIQWTF-WPZCJLIBSA-N 0.000 description 1
• AEDCKFVBPMSJHH-LRHAYUFXSA-N (2r)-2-[2-[4-(4-fluorophenyl)phenyl]ethyl]-4-methylpentanedioic acid Chemical compound C1=CC(CC[C@H](CC(C)C(O)=O)C(O)=O)=CC=C1C1=CC=C(F)C=C1 AEDCKFVBPMSJHH-LRHAYUFXSA-N 0.000 description 1
• LHMNZAZKPXEKKW-FQNRMIAFSA-N (2r)-2-[2-[4-(4-hydroxybutyl)phenyl]ethyl]-4-methylpentanedioic acid Chemical compound OC(=O)C(C)C[C@H](C(O)=O)CCC1=CC=C(CCCCO)C=C1 LHMNZAZKPXEKKW-FQNRMIAFSA-N 0.000 description 1
• RURYYOFWYCPJIQ-XPKAQORNSA-N (2r)-2-[2-[4-(4-methoxyphenyl)phenyl]ethyl]-4-methylpentanedioic acid Chemical compound C1=CC(OC)=CC=C1C1=CC=C(CC[C@H](CC(C)C(O)=O)C(O)=O)C=C1 RURYYOFWYCPJIQ-XPKAQORNSA-N 0.000 description 1
• PEYDLXUGPQEGEZ-SXOMAYOGSA-N (2r)-2-[[(2s)-1-(3,4-dihydro-1h-isoquinolin-2-yl)-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound C1CC2=CC=CC=C2CN1C(=O)[C@H](CC(C)C)N[C@@H](C(O)=O)CCN1C(=O)C2=CC3=CC=CC=C3C=C2C1=O PEYDLXUGPQEGEZ-SXOMAYOGSA-N 0.000 description 1
• ICHGEUHTXANQHK-RPWUZVMVSA-N (2r)-2-[[(2s)-1-(benzenesulfonamido)-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NS(=O)(=O)C1=CC=CC=C1 ICHGEUHTXANQHK-RPWUZVMVSA-N 0.000 description 1
• WFKFYEWTXWNLSQ-SXOMAYOGSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxo-5-phenylisoindol-2-yl)butanoic acid Chemical compound C([C@@H](N[C@@H](CC(C)C)C(=O)NCC=1C=CC=CC=1)C(O)=O)CN(C(C1=C2)=O)C(=O)C1=CC=C2C1=CC=CC=C1 WFKFYEWTXWNLSQ-SXOMAYOGSA-N 0.000 description 1
• IIWFEGCSOXADGA-IZLXSDGUSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxo-5-phenylmethoxyisoindol-2-yl)butanoic acid Chemical compound C([C@@H](N[C@@H](CC(C)C)C(=O)NCC=1C=CC=CC=1)C(O)=O)CN(C(C1=C2)=O)C(=O)C1=CC=C2OCC1=CC=CC=C1 IIWFEGCSOXADGA-IZLXSDGUSA-N 0.000 description 1
• OEVLRZHPDAKFSL-RPBOFIJWSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC=C1 OEVLRZHPDAKFSL-RPBOFIJWSA-N 0.000 description 1
• JTBZFSJOPYDYET-RTWAWAEBSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxoisoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC=CC=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC=C1 JTBZFSJOPYDYET-RTWAWAEBSA-N 0.000 description 1
• PMIJVUFNNNWTGM-RTWAWAEBSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(5-bromo-1,3-dioxoisoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC(Br)=CC=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC=C1 PMIJVUFNNNWTGM-RTWAWAEBSA-N 0.000 description 1
• MYKPZWYAUWGNBK-RTWAWAEBSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(5-hydroxy-1,3-dioxoisoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC(O)=CC=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC=C1 MYKPZWYAUWGNBK-RTWAWAEBSA-N 0.000 description 1
• NRTVWBJZZYOKED-YADHBBJMSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(5-methoxy-1,3-dioxoisoindol-2-yl)butanoic acid Chemical compound O=C([C@H](CC(C)C)N[C@H](CCN1C(=O)C2=CC=C(C=C2C1=O)OC)C(O)=O)NCC1=CC=CC=C1 NRTVWBJZZYOKED-YADHBBJMSA-N 0.000 description 1
• IXTKFCQDFVQZER-YADHBBJMSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(5-methyl-1,3-dioxoisoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC(C)=CC=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC=C1 IXTKFCQDFVQZER-YADHBBJMSA-N 0.000 description 1
• VCHWUNXMFWLHLZ-RTWAWAEBSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(5-nitro-1,3-dioxoisoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC(=CC=C2C1=O)[N+]([O-])=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC=C1 VCHWUNXMFWLHLZ-RTWAWAEBSA-N 0.000 description 1
• SXQIDVASQRSUIF-YADHBBJMSA-N (2r)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-[5-(methanesulfonamido)-1,3-dioxoisoindol-2-yl]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC(NS(C)(=O)=O)=CC=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC=C1 SXQIDVASQRSUIF-YADHBBJMSA-N 0.000 description 1
• FICMSWGEHHLVLO-UXHICEINSA-N (2r)-2-[[(2s)-1-(dimethylamino)-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound C1=CC=C2C=C(C(N(CC[C@@H](N[C@@H](CC(C)C)C(=O)N(C)C)C(O)=O)C3=O)=O)C3=CC2=C1 FICMSWGEHHLVLO-UXHICEINSA-N 0.000 description 1
• OWGNKOYIRGADIM-RPBOFIJWSA-N (2r)-2-[[(2s)-1-[(2,4-difluorophenyl)methylamino]-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=C(F)C=C1F OWGNKOYIRGADIM-RPBOFIJWSA-N 0.000 description 1
• MHBFBUKLOWTBPY-RPBOFIJWSA-N (2r)-2-[[(2s)-1-[(3,4-difluorophenyl)methylamino]-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=C(F)C(F)=C1 MHBFBUKLOWTBPY-RPBOFIJWSA-N 0.000 description 1
• BNKKKKHJWPHQMB-RPBOFIJWSA-N (2r)-2-[[(2s)-1-[(3,5-difluorophenyl)methylamino]-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC(F)=CC(F)=C1 BNKKKKHJWPHQMB-RPBOFIJWSA-N 0.000 description 1
• VLTRWQKUUNJZKL-MOPGFXCFSA-N (2r)-2-[[(2s)-1-[(3-amino-1h-1,2,4-triazol-5-yl)methylamino]-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=NN=C(N)N1 VLTRWQKUUNJZKL-MOPGFXCFSA-N 0.000 description 1
• IYOAFRYUFXIURS-RPBOFIJWSA-N (2r)-2-[[(2s)-1-[(3-aminophenyl)methylamino]-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC(N)=C1 IYOAFRYUFXIURS-RPBOFIJWSA-N 0.000 description 1
• AZLHBMNZAQOGTN-PKTZIBPZSA-N (2r)-2-[[(2s)-1-[2-(dimethylamino)ethyl-methylamino]-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound C1=CC=C2C=C(C(N(CC[C@@H](N[C@@H](CC(C)C)C(=O)N(C)CCN(C)C)C(O)=O)C3=O)=O)C3=CC2=C1 AZLHBMNZAQOGTN-PKTZIBPZSA-N 0.000 description 1
• HINNHPLLAXUVHW-DSNGMDLFSA-N (2r)-2-[[(2s)-1-[[(3s)-1-azabicyclo[2.2.2]octan-3-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound C1N(CC2)CCC2[C@@H]1NC(=O)[C@H](CC(C)C)N[C@@H](C(O)=O)CCN1C(=O)C2=CC3=CC=CC=C3C=C2C1=O HINNHPLLAXUVHW-DSNGMDLFSA-N 0.000 description 1
• LRKDRDGVDDKDFI-RTWAWAEBSA-N (2r)-2-[[(2s)-1-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound C1=CC=C2C=C(C(N(CC[C@@H](N[C@@H](CC(C)C)C(=O)NC(CO)(CO)CO)C(O)=O)C3=O)=O)C3=CC2=C1 LRKDRDGVDDKDFI-RTWAWAEBSA-N 0.000 description 1
• TYAVDVGXMWMREO-SXOMAYOGSA-N (2r)-2-[[(2s)-1-[[4-(dimethylamino)phenyl]methylamino]-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=C(N(C)C)C=C1 TYAVDVGXMWMREO-SXOMAYOGSA-N 0.000 description 1
• QTEIHMLBMPKKIZ-RPWUZVMVSA-N (2r)-2-[[(2s)-1-anilino-4-methyl-1-oxopentan-2-yl]amino]-4-(1,3-dioxobenzo[f]isoindol-2-yl)butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NC1=CC=CC=C1 QTEIHMLBMPKKIZ-RPWUZVMVSA-N 0.000 description 1
• VKUYLANQOAKALN-LJQANCHMSA-N (2r)-2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N([C@H](CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-LJQANCHMSA-N 0.000 description 1
• NGBPLGFXVZXMPW-HXUWFJFHSA-N (2r)-2-cyclohexyl-n-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]acetamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N([C@H](C1CCCCC1)C(=O)NO)CC1=CC=CN=C1 NGBPLGFXVZXMPW-HXUWFJFHSA-N 0.000 description 1
• GAUZBXUVFZCFTL-HXUWFJFHSA-N (2r)-2-cyclohexyl-n-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-4-ylmethyl)amino]acetamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N([C@H](C1CCCCC1)C(=O)NO)CC1=CC=NC=C1 GAUZBXUVFZCFTL-HXUWFJFHSA-N 0.000 description 1
• KLTRUHCZEUFBCI-RTWAWAEBSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-(1h-imidazol-2-ylmethylamino)-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=NC=CN1 KLTRUHCZEUFBCI-RTWAWAEBSA-N 0.000 description 1
• CYBSMERYJUUFBI-UXHICEINSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-(ethoxyamino)-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound C1=CC=C2C=C(C(N(CC[C@@H](N[C@@H](CC(C)C)C(=O)NOCC)C(O)=O)C3=O)=O)C3=CC2=C1 CYBSMERYJUUFBI-UXHICEINSA-N 0.000 description 1
• PQOOUARTOVKHRG-PKTZIBPZSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-(furan-2-ylmethylamino)-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CO1 PQOOUARTOVKHRG-PKTZIBPZSA-N 0.000 description 1
• ULPAGNYBENCMFT-XDQLBQEWSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-[(1,1-dioxothiolan-3-yl)-methylamino]-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)N(C)C1CCS(=O)(=O)C1 ULPAGNYBENCMFT-XDQLBQEWSA-N 0.000 description 1
• XQLNWPJNKWCJNN-YPFKAFGZSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-[(1,1-dioxothiolan-3-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NC1CCS(=O)(=O)C1 XQLNWPJNKWCJNN-YPFKAFGZSA-N 0.000 description 1
• ZPYLLHLHJRMHKM-RPBOFIJWSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-[(3-fluorophenyl)methylamino]-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC(F)=C1 ZPYLLHLHJRMHKM-RPBOFIJWSA-N 0.000 description 1
• AMUUVVZQQBNBAH-GEOZSUPMSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-[(4-hydroxy-1,1-dioxothiolan-3-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NC1CS(=O)(=O)CC1O AMUUVVZQQBNBAH-GEOZSUPMSA-N 0.000 description 1
• XPJMBJXJAGTHDT-PKTZIBPZSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-[2-(1h-imidazol-5-yl)ethylamino]-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCCC1=CNC=N1 XPJMBJXJAGTHDT-PKTZIBPZSA-N 0.000 description 1
• BZTLVCPAWKZLOX-RPBOFIJWSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-[4-(2-ethoxy-2-oxoethyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound C1CN(CC(=O)OCC)CCN1C(=O)[C@H](CC(C)C)N[C@@H](C(O)=O)CCN1C(=O)C2=CC3=CC=CC=C3C=C2C1=O BZTLVCPAWKZLOX-RPBOFIJWSA-N 0.000 description 1
• WOBWRLFGKFTTIW-FTJBHMTQSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-1-[[4-(methanesulfonamido)phenyl]methylamino]-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=C(NS(C)(=O)=O)C=C1 WOBWRLFGKFTTIW-FTJBHMTQSA-N 0.000 description 1
• HKQCSEWOGBFFLV-RPWUZVMVSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-(2-morpholin-4-ylethylamino)-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCCN1CCOCC1 HKQCSEWOGBFFLV-RPWUZVMVSA-N 0.000 description 1
• IHNXSBCQZROJCS-PKTZIBPZSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)N1CCN(C)CC1 IHNXSBCQZROJCS-PKTZIBPZSA-N 0.000 description 1
• CLDWFWQEHSJBDI-MOPGFXCFSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-(methylamino)-1-oxopentan-2-yl]amino]butanoic acid Chemical compound C1=CC=C2C=C(C(N(CC[C@@H](N[C@@H](CC(C)C)C(=O)NC)C(O)=O)C3=O)=O)C3=CC2=C1 CLDWFWQEHSJBDI-MOPGFXCFSA-N 0.000 description 1
• PUWSCJOQJNHFGL-UXHICEINSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-[(1-methyltetrazol-5-yl)methylamino]-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=NN=NN1C PUWSCJOQJNHFGL-UXHICEINSA-N 0.000 description 1
• XNTKFDGCIFUJAN-PKTZIBPZSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-[(2-methyl-6-oxo-1h-pyrimidin-5-yl)methylamino]-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CN=C(C)N=C1O XNTKFDGCIFUJAN-PKTZIBPZSA-N 0.000 description 1
• QNXOSJQPBDWRPV-RPBOFIJWSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-[(3-nitrophenyl)methylamino]-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC([N+]([O-])=O)=C1 QNXOSJQPBDWRPV-RPBOFIJWSA-N 0.000 description 1
• KLJSQIJCCPJROZ-YADHBBJMSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-morpholin-4-yl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)N1CCOCC1 KLJSQIJCCPJROZ-YADHBBJMSA-N 0.000 description 1
• QQTWJGZZLJPVHO-OEBVTXOESA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-(1,2,3,4-tetrahydronaphthalen-1-ylamino)pentan-2-yl]amino]butanoic acid Chemical compound C1CCC2=CC=CC=C2C1NC(=O)[C@H](CC(C)C)N[C@@H](C(O)=O)CCN1C(=O)C2=CC3=CC=CC=C3C=C2C1=O QQTWJGZZLJPVHO-OEBVTXOESA-N 0.000 description 1
• QMKYZDVPHOZDSO-YADHBBJMSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-(1-oxo-1,4-thiazinan-4-yl)pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)N1CCS(=O)CC1 QMKYZDVPHOZDSO-YADHBBJMSA-N 0.000 description 1
• YSOWDIROXDYGJM-FTJBHMTQSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-(2-phenylethylamino)pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCCC1=CC=CC=C1 YSOWDIROXDYGJM-FTJBHMTQSA-N 0.000 description 1
• IHBSZDNHPBSBLA-MOPGFXCFSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-(2h-tetrazol-5-ylmethylamino)pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=NN=NN1 IHBSZDNHPBSBLA-MOPGFXCFSA-N 0.000 description 1
• NNVXDWFDXUUTGZ-RPWUZVMVSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-(3-sulfamoylanilino)pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NC1=CC=CC(S(N)(=O)=O)=C1 NNVXDWFDXUUTGZ-RPWUZVMVSA-N 0.000 description 1
• RDJGJYMSLQWMKD-RPWUZVMVSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-(4-sulfamoylanilino)pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NC1=CC=C(S(N)(=O)=O)C=C1 RDJGJYMSLQWMKD-RPWUZVMVSA-N 0.000 description 1
• STUVZGRGAUKZRU-RPWUZVMVSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-(pyridin-2-ylmethylamino)pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC=N1 STUVZGRGAUKZRU-RPWUZVMVSA-N 0.000 description 1
• SPOBJYWTQVMQBU-RPWUZVMVSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-(pyridin-4-ylmethylamino)pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=NC=C1 SPOBJYWTQVMQBU-RPWUZVMVSA-N 0.000 description 1
• GSCAICSUTUHIKD-KWXIBIRDSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[(2r)-2-pyridin-3-ylpyrrolidin-1-yl]pentan-2-yl]amino]butanoic acid Chemical compound C1([C@H]2CCCN2C(=O)[C@@H](N[C@H](CCN2C(C3=CC4=CC=CC=C4C=C3C2=O)=O)C(O)=O)CC(C)C)=CC=CN=C1 GSCAICSUTUHIKD-KWXIBIRDSA-N 0.000 description 1
• FVPFSBPZTBSLES-KWXIBIRDSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[(2r)-3-oxo-2-phenylpiperazin-1-yl]pentan-2-yl]amino]butanoic acid Chemical compound C1([C@@H]2C(=O)NCCN2C(=O)[C@@H](N[C@H](CCN2C(C3=CC4=CC=CC=C4C=C3C2=O)=O)C(O)=O)CC(C)C)=CC=CC=C1 FVPFSBPZTBSLES-KWXIBIRDSA-N 0.000 description 1
• GSCAICSUTUHIKD-PVHODMMVSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[(2s)-2-pyridin-3-ylpyrrolidin-1-yl]pentan-2-yl]amino]butanoic acid Chemical compound C1([C@@H]2CCCN2C(=O)[C@@H](N[C@H](CCN2C(C3=CC4=CC=CC=C4C=C3C2=O)=O)C(O)=O)CC(C)C)=CC=CN=C1 GSCAICSUTUHIKD-PVHODMMVSA-N 0.000 description 1
• FVPFSBPZTBSLES-PVHODMMVSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[(2s)-3-oxo-2-phenylpiperazin-1-yl]pentan-2-yl]amino]butanoic acid Chemical compound C1([C@H]2C(=O)NCCN2C(=O)[C@@H](N[C@H](CCN2C(C3=CC4=CC=CC=C4C=C3C2=O)=O)C(O)=O)CC(C)C)=CC=CC=C1 FVPFSBPZTBSLES-PVHODMMVSA-N 0.000 description 1
• BOROQFAWARDBDC-RPBOFIJWSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[(4-sulfamoylphenyl)methylamino]pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=C(S(N)(=O)=O)C=C1 BOROQFAWARDBDC-RPBOFIJWSA-N 0.000 description 1
• XDYXNRAZWFJWNQ-RREDXGFBSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[1-(6-oxo-1h-pyridazin-3-yl)ethylamino]pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NC(C)C=1C=CC(=O)NN=1 XDYXNRAZWFJWNQ-RREDXGFBSA-N 0.000 description 1
• UAZHKINNICKCCP-BAEUJYSMSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[(1r)-1-phenylethyl]amino]pentan-2-yl]amino]butanoic acid Chemical compound C1([C@@H](C)NC(=O)[C@@H](N[C@H](CCN2C(C3=CC4=CC=CC=C4C=C3C2=O)=O)C(O)=O)CC(C)C)=CC=CC=C1 UAZHKINNICKCCP-BAEUJYSMSA-N 0.000 description 1
• UAZHKINNICKCCP-YZYNAAERSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[(1s)-1-phenylethyl]amino]pentan-2-yl]amino]butanoic acid Chemical compound C1([C@H](C)NC(=O)[C@@H](N[C@H](CCN2C(C3=CC4=CC=CC=C4C=C3C2=O)=O)C(O)=O)CC(C)C)=CC=CC=C1 UAZHKINNICKCCP-YZYNAAERSA-N 0.000 description 1
• OGMYPFNPKBZPNP-NJYVYQBISA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[(3r)-2-oxothiolan-3-yl]amino]pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)N[C@@H]1CCSC1=O OGMYPFNPKBZPNP-NJYVYQBISA-N 0.000 description 1
• OGMYPFNPKBZPNP-HKBOAZHASA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[(3s)-2-oxothiolan-3-yl]amino]pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)N[C@H]1CCSC1=O OGMYPFNPKBZPNP-HKBOAZHASA-N 0.000 description 1
• KXKANFPJEICPJZ-RPBOFIJWSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[3-(trifluoromethyl)phenyl]methylamino]pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC(C(F)(F)F)=C1 KXKANFPJEICPJZ-RPBOFIJWSA-N 0.000 description 1
• OUUQOUFSOFLOSC-RPBOFIJWSA-N (2r)-4-(1,3-dioxobenzo[f]isoindol-2-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[4-(trifluoromethylsulfonylamino)phenyl]methylamino]pentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=C(NS(=O)(=O)C(F)(F)F)C=C1 OUUQOUFSOFLOSC-RPBOFIJWSA-N 0.000 description 1
• BSMPGMPMFGAQGS-RTWAWAEBSA-N (2r)-4-(5-amino-1,3-dioxoisoindol-2-yl)-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC(N)=CC=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=CC=C1 BSMPGMPMFGAQGS-RTWAWAEBSA-N 0.000 description 1
• FOBJBXPKRCKRHZ-SXOMAYOGSA-N (2r)-4-[5-(benzenesulfonamido)-1,3-dioxoisoindol-2-yl]-2-[[(2s)-1-(benzylamino)-4-methyl-1-oxopentan-2-yl]amino]butanoic acid Chemical compound C([C@@H](N[C@@H](CC(C)C)C(=O)NCC=1C=CC=CC=1)C(O)=O)CN(C(C1=C2)=O)C(=O)C1=CC=C2NS(=O)(=O)C1=CC=CC=C1 FOBJBXPKRCKRHZ-SXOMAYOGSA-N 0.000 description 1
• DEFJQIDDEAULHB-BKLSDQPFSA-N (2s)-2-(2-aminopropanoylamino)propanoic acid Chemical compound CC(N)C(=O)N[C@@H](C)C(O)=O DEFJQIDDEAULHB-BKLSDQPFSA-N 0.000 description 1
• JWHMHRXXUPPKGV-INIZCTEOSA-N (2s)-2-(dibenzofuran-3-ylsulfonylamino)-3-methylbutanoic acid Chemical compound C1=CC=C2C3=CC=C(S(=O)(=O)N[C@@H](C(C)C)C(O)=O)C=C3OC2=C1 JWHMHRXXUPPKGV-INIZCTEOSA-N 0.000 description 1
• JJPPFLGOODJQBO-LBPRGKRZSA-N (2s)-2-(dibenzofuran-3-ylsulfonylamino)butanedioic acid Chemical compound C1=CC=C2C3=CC=C(S(=O)(=O)N[C@@H](CC(=O)O)C(O)=O)C=C3OC2=C1 JJPPFLGOODJQBO-LBPRGKRZSA-N 0.000 description 1
• WTKYBFQVZPCGAO-LURJTMIESA-N (2s)-2-(pyridin-3-ylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC1=CC=CN=C1 WTKYBFQVZPCGAO-LURJTMIESA-N 0.000 description 1
• HLORENITWPXINR-CVRLYYSRSA-N (2s)-2-[2-[4-(3-hydroxypropyl)phenyl]ethyl]-4-methylpentanedioic acid Chemical compound OC(=O)C(C)C[C@@H](C(O)=O)CCC1=CC=C(CCCO)C=C1 HLORENITWPXINR-CVRLYYSRSA-N 0.000 description 1
• GSCKLBZEPMMUCA-FQEVSTJZSA-N (2s)-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)C=1C=CC(Br)=CC=1)C1=CC=CC=C1 GSCKLBZEPMMUCA-FQEVSTJZSA-N 0.000 description 1
• NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
• NPDBDJFLKKQMCM-SCSAIBSYSA-N (2s)-2-amino-3,3-dimethylbutanoic acid Chemical compound CC(C)(C)[C@H](N)C(O)=O NPDBDJFLKKQMCM-SCSAIBSYSA-N 0.000 description 1
• NUXUIBNLDBQZLX-LFBMMIFQSA-N (2s)-2-amino-4-methylpentanoic acid;(2r)-2-[[(1s)-1-carboxy-3-phenylpropyl]amino]-6-(3-oxo-1h-isoindol-2-yl)hexanoic acid Chemical compound CC(C)C[C@H](N)C(O)=O.C([C@H](N[C@H](CCCCN1C(C2=CC=CC=C2C1)=O)C(=O)O)C(O)=O)CC1=CC=CC=C1 NUXUIBNLDBQZLX-LFBMMIFQSA-N 0.000 description 1
• RMXHQRJWJYIQQK-SYCLBLQOSA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;(2r)-2-[[(1s)-1-carboxy-3-phenylpropyl]amino]-6-(3-oxo-1h-isoindol-2-yl)hexanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.C([C@H](N[C@H](CCCCN1C(C2=CC=CC=C2C1)=O)C(=O)O)C(O)=O)CC1=CC=CC=C1 RMXHQRJWJYIQQK-SYCLBLQOSA-N 0.000 description 1
• PLCPLXITTDSMSK-INIZCTEOSA-N (2s)-3-methyl-2-[[4-(4-nitrophenyl)phenyl]sulfonylamino]butanoic acid Chemical compound C1=CC(S(=O)(=O)N[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=C([N+]([O-])=O)C=C1 PLCPLXITTDSMSK-INIZCTEOSA-N 0.000 description 1
• MCBFGLOCAYSWIG-IBGZPJMESA-N (2s)-4-dibenzofuran-2-yl-2-(octanoylamino)-4-oxobutanoic acid Chemical compound C1=CC=C2C3=CC(C(=O)C[C@H](NC(=O)CCCCCCC)C(O)=O)=CC=C3OC2=C1 MCBFGLOCAYSWIG-IBGZPJMESA-N 0.000 description 1
• NMQRDRTWRRRJMA-QTEQDKRBSA-N (2s,4r)-2-butyl-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]-6-[2-(1,3-oxazol-4-yl)phenyl]hexanoic acid Chemical compound C([C@H](C[C@H](CCCC)C(O)=O)C(=O)N1[C@@H](CCCN1)C(=O)NC)CC1=CC=CC=C1C1=COC=N1 NMQRDRTWRRRJMA-QTEQDKRBSA-N 0.000 description 1
• AJJNPAOFABBBSQ-QTEQDKRBSA-N (2s,4r)-2-butyl-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]-6-[2-(1,3-thiazol-4-yl)phenyl]hexanoic acid Chemical compound C([C@H](C[C@H](CCCC)C(O)=O)C(=O)N1[C@@H](CCCN1)C(=O)NC)CC1=CC=CC=C1C1=CSC=N1 AJJNPAOFABBBSQ-QTEQDKRBSA-N 0.000 description 1
• WQIFYYWGPPXAEB-GIWBLDEGSA-N (2s,4r)-2-butyl-6-(4-tert-butylphenyl)-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]hexanoic acid Chemical class C([C@H](C[C@H](CCCC)C(O)=O)C(=O)N1[C@@H](CCCN1)C(=O)NC)CC1=CC=C(C(C)(C)C)C=C1 WQIFYYWGPPXAEB-GIWBLDEGSA-N 0.000 description 1
• PEBSIVPSJFEBIH-QTEQDKRBSA-N (2s,4r)-2-butyl-6-[2-(1h-imidazol-5-yl)phenyl]-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]hexanoic acid Chemical compound C([C@H](C[C@H](CCCC)C(O)=O)C(=O)N1[C@@H](CCCN1)C(=O)NC)CC1=CC=CC=C1C1=CN=CN1 PEBSIVPSJFEBIH-QTEQDKRBSA-N 0.000 description 1
• AUQXIHYGFLFQJD-USZFVNFHSA-N (2s,4r)-2-butyl-6-[4-(4-fluorophenyl)phenyl]-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]hexanoic acid Chemical compound C([C@H](C[C@H](CCCC)C(O)=O)C(=O)N1[C@@H](CCCN1)C(=O)NC)CC(C=C1)=CC=C1C1=CC=C(F)C=C1 AUQXIHYGFLFQJD-USZFVNFHSA-N 0.000 description 1
• YSBPPJVKZKAIHF-VJBWXMMDSA-N (2s,4r)-2-butyl-6-[4-[(dimethylamino)methyl]phenyl]-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]hexanoic acid Chemical compound C([C@H](C[C@H](CCCC)C(O)=O)C(=O)N1[C@@H](CCCN1)C(=O)NC)CC1=CC=C(CN(C)C)C=C1 YSBPPJVKZKAIHF-VJBWXMMDSA-N 0.000 description 1
• KUGJOAKBWCLXEE-VPWXQRGCSA-N (2s,4r)-2-methyl-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]-6-[2-(1,3-oxazol-4-yl)phenyl]hexanoic acid Chemical compound CNC(=O)[C@@H]1CCCNN1C(=O)[C@@H](C[C@H](C)C(O)=O)CCC1=CC=CC=C1C1=COC=N1 KUGJOAKBWCLXEE-VPWXQRGCSA-N 0.000 description 1
• PRPWIDNKXWHYGQ-VPWXQRGCSA-N (2s,4r)-2-methyl-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]-6-[2-(1,3-thiazol-4-yl)phenyl]hexanoic acid Chemical compound CNC(=O)[C@@H]1CCCNN1C(=O)[C@@H](C[C@H](C)C(O)=O)CCC1=CC=CC=C1C1=CSC=N1 PRPWIDNKXWHYGQ-VPWXQRGCSA-N 0.000 description 1
• KMHOOSGVDMNQEJ-QQNWGBJXSA-N (2s,4r)-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]-6-[2-(1,3-oxazol-4-yl)phenyl]-2-(3-phenylpropyl)hexanoic acid Chemical compound CNC(=O)[C@@H]1CCCNN1C(=O)[C@@H](C[C@H](CCCC=1C=CC=CC=1)C(O)=O)CCC1=CC=CC=C1C1=COC=N1 KMHOOSGVDMNQEJ-QQNWGBJXSA-N 0.000 description 1
• NNHGBKOOUBDMGL-VPWXQRGCSA-N (2s,4r)-6-[2-(1h-imidazol-5-yl)phenyl]-2-methyl-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]hexanoic acid Chemical compound CNC(=O)[C@@H]1CCCNN1C(=O)[C@@H](C[C@H](C)C(O)=O)CCC1=CC=CC=C1C1=CN=CN1 NNHGBKOOUBDMGL-VPWXQRGCSA-N 0.000 description 1
• ZUKJSHRYSDDETJ-LXBDKUERSA-N (2s,4r)-6-[4-(4-fluorophenyl)phenyl]-2-methyl-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]hexanoic acid Chemical compound CNC(=O)[C@@H]1CCCNN1C(=O)[C@@H](C[C@H](C)C(O)=O)CCC1=CC=C(C=2C=CC(F)=CC=2)C=C1 ZUKJSHRYSDDETJ-LXBDKUERSA-N 0.000 description 1
• HAQVDDMGYVTONN-DBVUQKKJSA-N (2s,4r)-6-[4-[(dimethylamino)methyl]phenyl]-2-methyl-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]hexanoic acid Chemical compound CNC(=O)[C@@H]1CCCNN1C(=O)[C@@H](C[C@H](C)C(O)=O)CCC1=CC=C(CN(C)C)C=C1 HAQVDDMGYVTONN-DBVUQKKJSA-N 0.000 description 1
• DBWVBKROPMXJCV-PKTNWEFCSA-N (2s,4r)-6-[4-[(dimethylamino)methyl]phenyl]-4-[(6s)-6-(methylcarbamoyl)diazinane-1-carbonyl]-2-(3-phenylpropyl)hexanoic acid Chemical compound CNC(=O)[C@@H]1CCCNN1C(=O)[C@@H](C[C@H](CCCC=1C=CC=CC=1)C(O)=O)CCC1=CC=C(CN(C)C)C=C1 DBWVBKROPMXJCV-PKTNWEFCSA-N 0.000 description 1
• WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
• PQTBEOWWLSYOIX-WUFLDLQOSA-N (3s)-2-[(2r)-2-[1-(hydroxyamino)-1-oxo-5-phenylpentan-2-yl]nonanoyl]-n-(2,2,6,6-tetramethylpiperidin-4-yl)diazinane-3-carboxamide Chemical compound ONC(=O)C([C@@H](CCCCCCC)C(=O)N1[C@@H](CCCN1)C(=O)NC1CC(C)(C)NC(C)(C)C1)CCCC1=CC=CC=C1 PQTBEOWWLSYOIX-WUFLDLQOSA-N 0.000 description 1
• QTIGZMMLNFOOJQ-PKHIMPSTSA-N (4-amino-1,3-dioxoisoindol-2-yl)methyl-[4-methyl-2-[[(2s)-4-methyl-1-(methylamino)-1-oxopentan-2-yl]carbamoyl]pentyl]phosphinic acid Chemical compound C1=CC(N)=C2C(=O)N(CP(O)(=O)CC(CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NC)C(=O)C2=C1 QTIGZMMLNFOOJQ-PKHIMPSTSA-N 0.000 description 1
• FLZSKPZOSZSSDZ-OZAIVSQSSA-N (4R)-2-[4-(phenylcarbamoylamino)butyl]-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound CCCc1ccc(CC[C@H](CC(CCCCNC(=O)Nc2ccccc2)C(O)=O)C(O)=O)cc1 FLZSKPZOSZSSDZ-OZAIVSQSSA-N 0.000 description 1
• RZSFYMUQTCRVON-XMMISQBUSA-N (4r)-2-(4-benzamidobutyl)-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound C1=CC(CCC)=CC=C1CC[C@@H](C(O)=O)CC(C(O)=O)CCCCNC(=O)C1=CC=CC=C1 RZSFYMUQTCRVON-XMMISQBUSA-N 0.000 description 1
• QNQGNSXNZJSZSY-MUMRKEEXSA-N (4r)-2-(4-cyanobutyl)-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound CCCC1=CC=C(CC[C@H](CC(CCCCC#N)C(O)=O)C(O)=O)C=C1 QNQGNSXNZJSZSY-MUMRKEEXSA-N 0.000 description 1
• AYCRNSGJVHQBHJ-ZMFCMNQTSA-N (4r)-2-[(3-methylphenyl)methyl]-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound C1=CC(CCC)=CC=C1CC[C@@H](C(O)=O)CC(C(O)=O)CC1=CC=CC(C)=C1 AYCRNSGJVHQBHJ-ZMFCMNQTSA-N 0.000 description 1
• AKVSUFMBIHANAS-FOIFJWKZSA-N (4r)-2-[4-(1,3-benzoxazol-2-yl)butyl]-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound C1=CC(CCC)=CC=C1CC[C@@H](C(O)=O)CC(C(O)=O)CCCCC1=NC2=CC=CC=C2O1 AKVSUFMBIHANAS-FOIFJWKZSA-N 0.000 description 1
• GRJVWGUXGDFEEB-BPGUCPLFSA-N (4r)-2-[4-(2,2-dimethylpropanoylamino)butyl]-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound CCCC1=CC=C(CC[C@H](CC(CCCCNC(=O)C(C)(C)C)C(O)=O)C(O)=O)C=C1 GRJVWGUXGDFEEB-BPGUCPLFSA-N 0.000 description 1
• IVMXZQQTSYCHDH-FOIFJWKZSA-N (4r)-2-[4-(cyclopentylamino)butyl]-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound C1=CC(CCC)=CC=C1CC[C@@H](C(O)=O)CC(C(O)=O)CCCCNC1CCCC1 IVMXZQQTSYCHDH-FOIFJWKZSA-N 0.000 description 1
• DSDDEIHDKYHERZ-OZAIVSQSSA-N (4r)-2-[4-(phenoxycarbonylamino)butyl]-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound C1=CC(CCC)=CC=C1CC[C@@H](C(O)=O)CC(C(O)=O)CCCCNC(=O)OC1=CC=CC=C1 DSDDEIHDKYHERZ-OZAIVSQSSA-N 0.000 description 1
• INGILRRCBBKOOV-QRWMCTBCSA-N (4r)-2-butyl-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound CCCCC(C(O)=O)C[C@H](C(O)=O)CCC1=CC=C(CCC)C=C1 INGILRRCBBKOOV-QRWMCTBCSA-N 0.000 description 1
• PMKUBOKLVJRAQK-GFOWMXPYSA-N (4r)-2-hexyl-4-[2-(4-propylphenyl)ethyl]pentanedioic acid Chemical compound CCCCCCC(C(O)=O)C[C@H](C(O)=O)CCC1=CC=C(CCC)C=C1 PMKUBOKLVJRAQK-GFOWMXPYSA-N 0.000 description 1
• ZKGZFOVLRVGZFZ-TVKKRMFBSA-N (4r)-2-methyl-4-(2-phenylethyl)pentanedioic acid Chemical compound OC(=O)C(C)C[C@H](C(O)=O)CCC1=CC=CC=C1 ZKGZFOVLRVGZFZ-TVKKRMFBSA-N 0.000 description 1
• KVUROUUXLLDMAK-XPKAQORNSA-N (4r)-2-methyl-4-[2-(4-phenylphenyl)ethyl]pentanedioic acid Chemical compound C1=CC(CC[C@H](CC(C)C(O)=O)C(O)=O)=CC=C1C1=CC=CC=C1 KVUROUUXLLDMAK-XPKAQORNSA-N 0.000 description 1
• GZPIOFOFOMERAS-XCWJXAQQSA-N (4r)-2-methyl-4-[2-[4-(4-methylphenyl)phenyl]ethyl]pentanedioic acid Chemical compound C1=CC(CC[C@H](CC(C)C(O)=O)C(O)=O)=CC=C1C1=CC=C(C)C=C1 GZPIOFOFOMERAS-XCWJXAQQSA-N 0.000 description 1
• KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 description 1
• 125000004747 1,1-dimethylethoxycarbonyl group Chemical group CC(C)(OC(=O)*)C 0.000 description 1
• YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
• NDOVLWQBFFJETK-UHFFFAOYSA-N 1,4-thiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCC1 NDOVLWQBFFJETK-UHFFFAOYSA-N 0.000 description 1
• LZGWJYFOISWDMK-UHFFFAOYSA-N 1-(dibenzofuran-2-ylsulfonylamino)cyclopropane-1-carboxylic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC1(C(=O)O)CC1 LZGWJYFOISWDMK-UHFFFAOYSA-N 0.000 description 1
• PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
• GHEDQUKBGPZPDO-UHFFFAOYSA-N 1-[2-(4-propylphenyl)ethyl]cyclohexane-1,3-dicarboxylic acid Chemical compound C1=CC(CCC)=CC=C1CCC1(C(O)=O)CC(C(O)=O)CCC1 GHEDQUKBGPZPDO-UHFFFAOYSA-N 0.000 description 1
• GICIYGLTLATGBM-UHFFFAOYSA-N 1-[2-(4-propylphenyl)ethyl]cyclopentane-1,3-dicarboxylic acid Chemical compound C1=CC(CCC)=CC=C1CCC1(C(O)=O)CC(C(O)=O)CC1 GICIYGLTLATGBM-UHFFFAOYSA-N 0.000 description 1
• ONQBOTKLCMXPOF-UHFFFAOYSA-N 1-ethylpyrrolidine Chemical compound CCN1CCCC1 ONQBOTKLCMXPOF-UHFFFAOYSA-N 0.000 description 1
• RUYZJEIKQYLEGZ-UHFFFAOYSA-N 1-fluoro-4-phenylbenzene Chemical group C1=CC(F)=CC=C1C1=CC=CC=C1 RUYZJEIKQYLEGZ-UHFFFAOYSA-N 0.000 description 1
• AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
• SWZKXIPDGAAYKE-UHFFFAOYSA-N 1-morpholin-4-ylpropan-2-amine Chemical compound CC(N)CN1CCOCC1 SWZKXIPDGAAYKE-UHFFFAOYSA-N 0.000 description 1
• FGOJCPKOOGIRPA-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 5-oxoazepane-1,4-dicarboxylate Chemical compound CCOC(=O)C1CCN(C(=O)OC(C)(C)C)CCC1=O FGOJCPKOOGIRPA-UHFFFAOYSA-N 0.000 description 1
• UCOSRTUSVXHIMK-UHFFFAOYSA-N 1h-benzimidazol-2-ylmethanamine Chemical compound C1=CC=C2NC(CN)=NC2=C1 UCOSRTUSVXHIMK-UHFFFAOYSA-N 0.000 description 1
• XDIAMRVROCPPBK-UHFFFAOYSA-N 2,2-dimethylpropan-1-amine Chemical compound CC(C)(C)CN XDIAMRVROCPPBK-UHFFFAOYSA-N 0.000 description 1
• ITFDYXKCBZEBDG-UHFFFAOYSA-N 2-(1-methylpyrrol-2-yl)ethanamine Chemical compound CN1C=CC=C1CCN ITFDYXKCBZEBDG-UHFFFAOYSA-N 0.000 description 1
• RUZFOVWVTZFBEY-UHFFFAOYSA-N 2-(2-dibenzofuran-2-yl-2-hydroxyiminoethyl)-4-methylpentanoic acid Chemical compound C1=CC=C2C3=CC(C(=NO)CC(CC(C)C)C(O)=O)=CC=C3OC2=C1 RUZFOVWVTZFBEY-UHFFFAOYSA-N 0.000 description 1
• HDBJBHBTWZQDCD-UHFFFAOYSA-N 2-(2-dibenzofuran-2-yl-2-hydroxyiminoethyl)-5-(4-fluorophenyl)pentanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1C(=NO)CC(C(O)=O)CCCC1=CC=C(F)C=C1 HDBJBHBTWZQDCD-UHFFFAOYSA-N 0.000 description 1
• SJPIHNMYAACOJG-UHFFFAOYSA-N 2-(2-dibenzofuran-2-yl-2-hydroxyiminoethyl)-5-(4-methoxyphenyl)pentanoic acid Chemical compound C1=CC(OC)=CC=C1CCCC(C(O)=O)CC(=NO)C1=CC=C(OC=2C3=CC=CC=2)C3=C1 SJPIHNMYAACOJG-UHFFFAOYSA-N 0.000 description 1
• ORTRKADJPCSNIV-UHFFFAOYSA-N 2-(2-dibenzofuran-2-yl-2-hydroxyiminoethyl)-5-(4-methylphenyl)pentanoic acid Chemical compound C1=CC(C)=CC=C1CCCC(C(O)=O)CC(=NO)C1=CC=C(OC=2C3=CC=CC=2)C3=C1 ORTRKADJPCSNIV-UHFFFAOYSA-N 0.000 description 1
• FYAJIJFVPRYYKV-UHFFFAOYSA-N 2-(2-dibenzofuran-2-yl-2-hydroxyiminoethyl)-5-phenylpentanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1C(=NO)CC(C(O)=O)CCCC1=CC=CC=C1 FYAJIJFVPRYYKV-UHFFFAOYSA-N 0.000 description 1
• TUOZACADWRCCNC-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-2-(4-methoxyphenyl)acetic acid Chemical compound C1=CC(OC)=CC=C1C(C(O)=O)NS(=O)(=O)C1=CC=C(OC=2C3=CC=CC=2)C3=C1 TUOZACADWRCCNC-UHFFFAOYSA-N 0.000 description 1
• JENZVHXFRQGOFL-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-2-phenylacetic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)C1=CC=CC=C1 JENZVHXFRQGOFL-UHFFFAOYSA-N 0.000 description 1
• QPCALSWJZUJWLK-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-3-(1h-imidazol-5-yl)propanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)CC1=CNC=N1 QPCALSWJZUJWLK-UHFFFAOYSA-N 0.000 description 1
• XDOAIHGEJMOGJF-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-3-(1h-indol-3-yl)propanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)NC(CC=4C5=CC=CC=C5NC=4)C(=O)O)=CC=C3OC2=C1 XDOAIHGEJMOGJF-UHFFFAOYSA-N 0.000 description 1
• SJPXJSANXSAHSU-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-3-(4-fluorophenyl)propanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)CC1=CC=C(F)C=C1 SJPXJSANXSAHSU-UHFFFAOYSA-N 0.000 description 1
• QUKJSCLIIFHJOF-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-3-(4-phenylmethoxyphenyl)propanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)CC(C=C1)=CC=C1OCC1=CC=CC=C1 QUKJSCLIIFHJOF-UHFFFAOYSA-N 0.000 description 1
• YJHTYBHIRIYXAV-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-3-[(2-methylpropan-2-yl)oxy]propanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)NC(COC(C)(C)C)C(O)=O)=CC=C3OC2=C1 YJHTYBHIRIYXAV-UHFFFAOYSA-N 0.000 description 1
• COJSFTGHLOFDLF-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-3-[4-[(2-methylpropan-2-yl)oxy]phenyl]propanoic acid Chemical compound C1=CC(OC(C)(C)C)=CC=C1CC(C(O)=O)NS(=O)(=O)C1=CC=C(OC=2C3=CC=CC=2)C3=C1 COJSFTGHLOFDLF-UHFFFAOYSA-N 0.000 description 1
• UFYNTEKFUSRPMK-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-3-hydroxypropanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)NC(CO)C(O)=O)=CC=C3OC2=C1 UFYNTEKFUSRPMK-UHFFFAOYSA-N 0.000 description 1
• SDUOASNEYVEUJP-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-3-phenylmethoxypropanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)COCC1=CC=CC=C1 SDUOASNEYVEUJP-UHFFFAOYSA-N 0.000 description 1
• DVIKVXSMRJYYDK-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-3-phenylpropanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)CC1=CC=CC=C1 DVIKVXSMRJYYDK-UHFFFAOYSA-N 0.000 description 1
• NOYWCELMDAGFET-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-4-sulfanylbutanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)NC(CCS)C(=O)O)=CC=C3OC2=C1 NOYWCELMDAGFET-UHFFFAOYSA-N 0.000 description 1
• RHESIYZDLRIXQI-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-5-(4-methylphenyl)-2-(sulfanylamino)pentanoic acid Chemical compound C1=CC(C)=CC=C1CCCC(NS)(C(O)=O)NS(=O)(=O)C1=CC=C(OC=2C3=CC=CC=2)C3=C1 RHESIYZDLRIXQI-UHFFFAOYSA-N 0.000 description 1
• DMQDCKWVHYQISX-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-5-(phenylmethoxycarbonylamino)pentanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)CCCNC(=O)OCC1=CC=CC=C1 DMQDCKWVHYQISX-UHFFFAOYSA-N 0.000 description 1
• CPAXWZYVQBSDOD-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)-6-(phenylmethoxycarbonylamino)hexanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)OCC1=CC=CC=C1 CPAXWZYVQBSDOD-UHFFFAOYSA-N 0.000 description 1
• VGLXBFPXVGHONM-UHFFFAOYSA-N 2-(dibenzofuran-2-ylsulfonylamino)butanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)NC(CC)C(O)=O)=CC=C3OC2=C1 VGLXBFPXVGHONM-UHFFFAOYSA-N 0.000 description 1
• WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 1
• MTRJGVMFMHSBCX-UHFFFAOYSA-N 2-[[2-[[4-(4-bromophenyl)phenyl]sulfonylamino]acetyl]amino]-6-phenylhexanoic acid Chemical compound BrC1=CC=C(C=C1)C1=CC=C(C=C1)S(=O)(=O)NCC(=O)NC(C(=O)O)CCCCC1=CC=CC=C1 MTRJGVMFMHSBCX-UHFFFAOYSA-N 0.000 description 1
• MEOHTIBKCWWFRM-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(2-methylpropoxycarbonylamino)hexanoic acid Chemical compound C1=CC(S(=O)(=O)NC(CCCCNC(=O)OCC(C)C)C(O)=O)=CC=C1C1=CC=C(Br)C=C1 MEOHTIBKCWWFRM-UHFFFAOYSA-N 0.000 description 1
• VFLNACNIZOYMQK-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(2-phenoxybutanoylamino)hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(O)=O)CCCCNC(=O)C(CC)OC1=CC=CC=C1 VFLNACNIZOYMQK-UHFFFAOYSA-N 0.000 description 1
• JRPGFSSCBLWDMU-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(2-phenylethenylsulfonylamino)hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNS(=O)(=O)C=CC1=CC=CC=C1 JRPGFSSCBLWDMU-UHFFFAOYSA-N 0.000 description 1
• ZYCHFPRCALZWEG-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(3-phenylprop-2-enoylamino)hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)C=CC1=CC=CC=C1 ZYCHFPRCALZWEG-UHFFFAOYSA-N 0.000 description 1
• JBXVKSCRNTWNDQ-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(4-phenylbutanoylamino)hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CCCC1=CC=CC=C1 JBXVKSCRNTWNDQ-UHFFFAOYSA-N 0.000 description 1
• JQAGVCGXDHYBPP-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(4-thiophen-2-ylbutanoylamino)hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CCCC1=CC=CS1 JQAGVCGXDHYBPP-UHFFFAOYSA-N 0.000 description 1
• LNTCNQRVHFQNPD-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(6-phenylhexanoylamino)hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CCCCCC1=CC=CC=C1 LNTCNQRVHFQNPD-UHFFFAOYSA-N 0.000 description 1
• DBXQAOWUJZDGHG-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(7-phenylheptanoylamino)hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CCCCCCC1=CC=CC=C1 DBXQAOWUJZDGHG-UHFFFAOYSA-N 0.000 description 1
• YIRKWGVPJPEILK-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(9h-fluoren-9-ylmethoxycarbonylamino)hexanoic acid Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1COC(=O)NCCCCC(C(=O)O)NS(=O)(=O)C(C=C1)=CC=C1C1=CC=C(Br)C=C1 YIRKWGVPJPEILK-UHFFFAOYSA-N 0.000 description 1
• FKNSXHLHWUDZGZ-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(naphthalen-1-ylsulfonylamino)hexanoic acid Chemical compound C=1C=CC2=CC=CC=C2C=1S(=O)(=O)NCCCCC(C(=O)O)NS(=O)(=O)C(C=C1)=CC=C1C1=CC=C(Br)C=C1 FKNSXHLHWUDZGZ-UHFFFAOYSA-N 0.000 description 1
• UZRHUJZRSKTUCF-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(naphthalen-2-ylsulfonylamino)hexanoic acid Chemical compound C=1C=C2C=CC=CC2=CC=1S(=O)(=O)NCCCCC(C(=O)O)NS(=O)(=O)C(C=C1)=CC=C1C1=CC=C(Br)C=C1 UZRHUJZRSKTUCF-UHFFFAOYSA-N 0.000 description 1
• RHNDFMCTIVLGNU-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-(pentylsulfonylamino)hexanoic acid Chemical compound C1=CC(S(=O)(=O)NC(CCCCNS(=O)(=O)CCCCC)C(O)=O)=CC=C1C1=CC=C(Br)C=C1 RHNDFMCTIVLGNU-UHFFFAOYSA-N 0.000 description 1
• PFGSDNWBFJHGSM-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(2-naphthalen-1-ylacetyl)amino]hexanoic acid Chemical compound C=1C=CC2=CC=CC=C2C=1CC(=O)NCCCCC(C(=O)O)NS(=O)(=O)C(C=C1)=CC=C1C1=CC=C(Br)C=C1 PFGSDNWBFJHGSM-UHFFFAOYSA-N 0.000 description 1
• HUZVKTZXGMIXHI-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(2-phenoxyacetyl)amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)COC1=CC=CC=C1 HUZVKTZXGMIXHI-UHFFFAOYSA-N 0.000 description 1
• OBACKHQOKPKNPH-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(2-phenylacetyl)-sulfanylamino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCN(S)C(=O)CC1=CC=CC=C1 OBACKHQOKPKNPH-UHFFFAOYSA-N 0.000 description 1
• VSINVXYMZZGHSR-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(2-pyridin-4-ylsulfanylacetyl)amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CSC1=CC=NC=C1 VSINVXYMZZGHSR-UHFFFAOYSA-N 0.000 description 1
• ZBNKGFPVBNPNHG-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(2-thiophen-2-ylacetyl)amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CC1=CC=CS1 ZBNKGFPVBNPNHG-UHFFFAOYSA-N 0.000 description 1
• JTSNKVXAGWTTQL-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(4-bromophenyl)sulfonylamino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNS(=O)(=O)C1=CC=C(Br)C=C1 JTSNKVXAGWTTQL-UHFFFAOYSA-N 0.000 description 1
• ICJJXTKALACFIO-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(4-fluorophenyl)sulfonylamino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNS(=O)(=O)C1=CC=C(F)C=C1 ICJJXTKALACFIO-UHFFFAOYSA-N 0.000 description 1
• NVRZZLBQPPYVGP-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[(4-methoxyphenyl)sulfonylamino]hexanoic acid Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=2C=CC(Br)=CC=2)C=C1 NVRZZLBQPPYVGP-UHFFFAOYSA-N 0.000 description 1
• JLSNAIYQQLQPEP-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[3-(4-chlorophenoxy)propanoylamino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CCOC1=CC=C(Cl)C=C1 JLSNAIYQQLQPEP-UHFFFAOYSA-N 0.000 description 1
• IHQHZDHUABWQAP-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[3-(4-chlorophenyl)propanoylamino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CCC1=CC=C(Cl)C=C1 IHQHZDHUABWQAP-UHFFFAOYSA-N 0.000 description 1
• RXZQFTBGLBOGKZ-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[4-(4-nitrophenyl)butanoylamino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CCCC1=CC=C([N+]([O-])=O)C=C1 RXZQFTBGLBOGKZ-UHFFFAOYSA-N 0.000 description 1
• VANLASLGRAWOAL-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2,4,6-tri(propan-2-yl)benzoyl]amino]hexanoic acid Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C(=O)NCCCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=2C=CC(Br)=CC=2)C=C1 VANLASLGRAWOAL-UHFFFAOYSA-N 0.000 description 1
• VEEKBYDZLWFBLA-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2-(2,4-dichlorophenoxy)acetyl]amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)COC1=CC=C(Cl)C=C1Cl VEEKBYDZLWFBLA-UHFFFAOYSA-N 0.000 description 1
• LXDNQRMWUMGTNW-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2-(3,4-dimethoxyphenyl)acetyl]amino]hexanoic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC(=O)NCCCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=2C=CC(Br)=CC=2)C=C1 LXDNQRMWUMGTNW-UHFFFAOYSA-N 0.000 description 1
• NLQUGPIPHDZLBU-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2-(4-chlorophenoxy)-2-methylpropanoyl]amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(O)=O)CCCCNC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 NLQUGPIPHDZLBU-UHFFFAOYSA-N 0.000 description 1
• YYUNOKHFOONFCA-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2-(4-chlorophenoxy)acetyl]amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)COC1=CC=C(Cl)C=C1 YYUNOKHFOONFCA-UHFFFAOYSA-N 0.000 description 1
• QPOWMJGPFJBSIM-UHFFFAOYSA-N 2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-6-[[2-[2-(trifluoromethyl)phenyl]acetyl]amino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNC(=O)CC1=CC=CC=C1C(F)(F)F QPOWMJGPFJBSIM-UHFFFAOYSA-N 0.000 description 1
• BNOKHOUVRPYUSP-UHFFFAOYSA-N 2-[benzyl(octylsulfonyl)amino]-n-hydroxyacetamide Chemical compound CCCCCCCCS(=O)(=O)N(CC(=O)NO)CC1=CC=CC=C1 BNOKHOUVRPYUSP-UHFFFAOYSA-N 0.000 description 1
• VKUYLANQOAKALN-UHFFFAOYSA-N 2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C(CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-UHFFFAOYSA-N 0.000 description 1
• ZKMLNPOVUPBBCF-UHFFFAOYSA-N 2-[decyl-(4-methylphenyl)sulfonylamino]-n-hydroxyacetamide Chemical compound CCCCCCCCCCN(CC(=O)NO)S(=O)(=O)C1=CC=C(C)C=C1 ZKMLNPOVUPBBCF-UHFFFAOYSA-N 0.000 description 1
• QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
• FZUBHJJEYNHYFU-DKWTVANSSA-N 2-aminoacetic acid;(2s)-2,4-diamino-4-oxobutanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CC(N)=O FZUBHJJEYNHYFU-DKWTVANSSA-N 0.000 description 1
• VDFRQZSFJVSJQY-WCCKRBBISA-N 2-aminoacetic acid;(2s)-2,5-diaminopentanoic acid Chemical compound NCC(O)=O.NCCC[C@H](N)C(O)=O VDFRQZSFJVSJQY-WCCKRBBISA-N 0.000 description 1
• BKKWZCSSYWYNDS-JEDNCBNOSA-N 2-aminoacetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCC(O)=O.NCCCC[C@H](N)C(O)=O BKKWZCSSYWYNDS-JEDNCBNOSA-N 0.000 description 1
• QPYGLMKJCFDDKV-FJXQXJEOSA-N 2-aminoacetic acid;(2s)-2-amino-2-phenylacetic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)C1=CC=CC=C1 QPYGLMKJCFDDKV-FJXQXJEOSA-N 0.000 description 1
• HVBRJSWZFSWZKB-FVGYRXGTSA-N 2-aminoacetic acid;(2s)-2-amino-3-(1h-indol-3-yl)propanoic acid Chemical compound NCC(O)=O.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 HVBRJSWZFSWZKB-FVGYRXGTSA-N 0.000 description 1
• FCWAUFMDOCOONS-QRPNPIFTSA-N 2-aminoacetic acid;(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FCWAUFMDOCOONS-QRPNPIFTSA-N 0.000 description 1
• ZVEUWSJUXREOBK-DKWTVANSSA-N 2-aminoacetic acid;(2s)-2-amino-3-hydroxypropanoic acid Chemical compound NCC(O)=O.OC[C@H](N)C(O)=O ZVEUWSJUXREOBK-DKWTVANSSA-N 0.000 description 1
• NYOGGQBMEGUVIX-WCCKRBBISA-N 2-aminoacetic acid;(2s)-2-amino-3-methylbutanoic acid Chemical compound NCC(O)=O.CC(C)[C@H](N)C(O)=O NYOGGQBMEGUVIX-WCCKRBBISA-N 0.000 description 1
• DQSIXGDDUJJEQH-QRPNPIFTSA-N 2-aminoacetic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 DQSIXGDDUJJEQH-QRPNPIFTSA-N 0.000 description 1
• LTDYEDCDJFHPFI-DKWTVANSSA-N 2-aminoacetic acid;(2s)-2-aminopropanoic acid Chemical compound NCC(O)=O.C[C@H](N)C(O)=O LTDYEDCDJFHPFI-DKWTVANSSA-N 0.000 description 1
• XGKCWNGHLZXLTK-MUWMCQJSSA-N 2-aminoacetic acid;(2s,3r)-2-amino-3-hydroxybutanoic acid Chemical compound NCC(O)=O.C[C@@H](O)[C@H](N)C(O)=O XGKCWNGHLZXLTK-MUWMCQJSSA-N 0.000 description 1
• MNQVNFIVCSQNGY-FHAQVOQBSA-N 2-aminoacetic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound NCC(O)=O.CC[C@H](C)[C@H](N)C(O)=O MNQVNFIVCSQNGY-FHAQVOQBSA-N 0.000 description 1
• UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical compound C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 description 1
• 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
• 125000003635 2-dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 description 1
• AWZLXVAPLHUDSY-UHFFFAOYSA-N 2-ethyl-1-methylpiperazine Chemical compound CCC1CNCCN1C AWZLXVAPLHUDSY-UHFFFAOYSA-N 0.000 description 1
• 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
• SEINETSKRAZANU-UHFFFAOYSA-N 2-methylsulfanyl-1h-indole Chemical group C1=CC=C2NC(SC)=CC2=C1 SEINETSKRAZANU-UHFFFAOYSA-N 0.000 description 1
• MIIIXQJBDGSIKL-UHFFFAOYSA-N 2-morpholin-4-ylethanesulfonic acid;hydrate Chemical compound O.OS(=O)(=O)CCN1CCOCC1 MIIIXQJBDGSIKL-UHFFFAOYSA-N 0.000 description 1
• XPQIPUZPSLAZDV-UHFFFAOYSA-N 2-pyridylethylamine Chemical compound NCCC1=CC=CC=N1 XPQIPUZPSLAZDV-UHFFFAOYSA-N 0.000 description 1
• WRXNJTBODVGDRY-UHFFFAOYSA-N 2-pyrrolidin-1-ylethanamine Chemical compound NCCN1CCCC1 WRXNJTBODVGDRY-UHFFFAOYSA-N 0.000 description 1
• BUFWBYAKDSEBFJ-UHFFFAOYSA-N 3-(4-bromophenyl)-2-(dibenzofuran-2-ylsulfonylamino)propanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)CC1=CC=C(Br)C=C1 BUFWBYAKDSEBFJ-UHFFFAOYSA-N 0.000 description 1
• CLUFNZTWUVTPGT-UHFFFAOYSA-N 3-(4-chlorophenyl)-2-(dibenzofuran-2-ylsulfonylamino)propanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1S(=O)(=O)NC(C(=O)O)CC1=CC=C(Cl)C=C1 CLUFNZTWUVTPGT-UHFFFAOYSA-N 0.000 description 1
• WWISHLRUOQVYLD-UHFFFAOYSA-N 3-(c-dibenzofuran-2-yl-n-hydroxycarbonimidoyl)-5-methylhexanoic acid Chemical compound C1=CC=C2C3=CC(C(=NO)C(CC(O)=O)CC(C)C)=CC=C3OC2=C1 WWISHLRUOQVYLD-UHFFFAOYSA-N 0.000 description 1
• XZIGLAWFTBSBMY-UHFFFAOYSA-N 3-(c-dibenzofuran-2-yl-n-hydroxycarbonimidoyl)-5-phenylpentanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1C(=NO)C(CC(O)=O)CCC1=CC=CC=C1 XZIGLAWFTBSBMY-UHFFFAOYSA-N 0.000 description 1
• FTFHWIIEOHDQBV-UHFFFAOYSA-N 3-(c-dibenzofuran-2-yl-n-hydroxycarbonimidoyl)-6-(4-fluorophenyl)hexanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1C(=NO)C(CC(O)=O)CCCC1=CC=C(F)C=C1 FTFHWIIEOHDQBV-UHFFFAOYSA-N 0.000 description 1
• OBVHTYKXSIHXDM-UHFFFAOYSA-N 3-(c-dibenzofuran-2-yl-n-hydroxycarbonimidoyl)-6-(4-methoxyphenyl)hexanoic acid Chemical compound C1=CC(OC)=CC=C1CCCC(CC(O)=O)C(=NO)C1=CC=C(OC=2C3=CC=CC=2)C3=C1 OBVHTYKXSIHXDM-UHFFFAOYSA-N 0.000 description 1
• IHWRMEDAWMDWND-UHFFFAOYSA-N 3-(c-dibenzofuran-2-yl-n-hydroxycarbonimidoyl)-6-(4-methylphenyl)hexanoic acid Chemical compound C1=CC(C)=CC=C1CCCC(CC(O)=O)C(=NO)C1=CC=C(OC=2C3=CC=CC=2)C3=C1 IHWRMEDAWMDWND-UHFFFAOYSA-N 0.000 description 1
• IIJQIZHHWVDHHV-UHFFFAOYSA-N 3-(c-dibenzofuran-2-yl-n-hydroxycarbonimidoyl)-6-phenylhexanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1C(=NO)C(CC(O)=O)CCCC1=CC=CC=C1 IIJQIZHHWVDHHV-UHFFFAOYSA-N 0.000 description 1
• LEVONNIFUFSRKZ-UHFFFAOYSA-N 3-(carboxymethyl)-2,2-dimethylcyclobutane-1-carboxylic acid Chemical compound CC1(C)C(CC(O)=O)CC1C(O)=O LEVONNIFUFSRKZ-UHFFFAOYSA-N 0.000 description 1
• WXDHEKCNKUOATG-UHFFFAOYSA-N 3-[(3,4-dimethoxyphenyl)sulfonyl-[2-(hydroxyamino)-2-oxoethyl]amino]propanoic acid Chemical compound COC1=CC=C(S(=O)(=O)N(CCC(O)=O)CC(=O)NO)C=C1OC WXDHEKCNKUOATG-UHFFFAOYSA-N 0.000 description 1
• CQZLEYBEPASILI-UHFFFAOYSA-N 3-amino-azacyclotridecan-2-one Chemical compound NC1CCCCCCCCCCNC1=O CQZLEYBEPASILI-UHFFFAOYSA-N 0.000 description 1
• CUYKNJBYIJFRCU-UHFFFAOYSA-N 3-aminopyridine Chemical compound NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 1
• IIJJEHHIFYIZAN-UHFFFAOYSA-N 3-chloro-2-(dibenzofuran-2-ylsulfonylamino)propanoic acid Chemical compound C1=CC=C2C3=CC(S(=O)(=O)NC(CCl)C(=O)O)=CC=C3OC2=C1 IIJJEHHIFYIZAN-UHFFFAOYSA-N 0.000 description 1
• 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 1
• 125000001137 3-hydroxypropoxy group Chemical group [H]OC([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
• KDHWOCLBMVSZPG-UHFFFAOYSA-N 3-imidazol-1-ylpropan-1-amine Chemical compound NCCCN1C=CN=C1 KDHWOCLBMVSZPG-UHFFFAOYSA-N 0.000 description 1
• UIKUBYKUYUSRSM-UHFFFAOYSA-N 3-morpholinopropylamine Chemical compound NCCCN1CCOCC1 UIKUBYKUYUSRSM-UHFFFAOYSA-N 0.000 description 1
• PGMZAQDZZPRHLE-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-2-[2-(1,3-dioxoisoindol-2-yl)ethyl]-2-fluoro-4-hydroxyiminobutanoic acid Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCC(F)(C(O)=O)CC(=NO)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1 PGMZAQDZZPRHLE-UHFFFAOYSA-N 0.000 description 1
• DMYQQPUOQMOFJU-RPBOFIJWSA-N 4-[[[(2s)-2-[[(1r)-1-carboxy-3-(1,3-dioxobenzo[f]isoindol-2-yl)propyl]amino]-4-methylpentanoyl]amino]methyl]benzoic acid Chemical compound O=C([C@@H](N[C@H](CCN1C(C2=CC3=CC=CC=C3C=C2C1=O)=O)C(O)=O)CC(C)C)NCC1=CC=C(C(O)=O)C=C1 DMYQQPUOQMOFJU-RPBOFIJWSA-N 0.000 description 1
• ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
• MVCBWNHTZDIVDM-UHFFFAOYSA-N 4-benzo[f]isoindol-2-ylbutanoic acid Chemical compound C1=CC=CC2=CC3=CN(CCCC(=O)O)C=C3C=C21 MVCBWNHTZDIVDM-UHFFFAOYSA-N 0.000 description 1
• 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
• 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
• NCSLXBHBPUGLDK-UHFFFAOYSA-N 4-dibenzofuran-2-yl-4-hydroxyimino-2-(2-phenylethyl)butanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1C(=NO)CC(C(O)=O)CCC1=CC=CC=C1 NCSLXBHBPUGLDK-UHFFFAOYSA-N 0.000 description 1
• ODQJWIMYDRXPBG-UHFFFAOYSA-N 4-dibenzofuran-2-yl-4-hydroxyiminobutanoic acid Chemical compound C1=CC=C2C3=CC(C(CCC(O)=O)=NO)=CC=C3OC2=C1 ODQJWIMYDRXPBG-UHFFFAOYSA-N 0.000 description 1
• 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
• UWDMKTDPDJCJOP-UHFFFAOYSA-N 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-ium-4-carboxylate Chemical compound CC1(C)CC(O)(C(O)=O)CC(C)(C)N1 UWDMKTDPDJCJOP-UHFFFAOYSA-N 0.000 description 1
• 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
• BNNMDMGPZUOOOE-UHFFFAOYSA-N 4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.CC1=CC=C(S(O)(=O)=O)C=C1 BNNMDMGPZUOOOE-UHFFFAOYSA-N 0.000 description 1
• ODGIMMLDVSWADK-UHFFFAOYSA-N 4-trifluoromethylaniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1 ODGIMMLDVSWADK-UHFFFAOYSA-N 0.000 description 1
• CZDKQKOAHAICSF-JSAMMMMSSA-N 4beta-hydroxycholesterol Chemical compound C1C=C2[C@@H](O)[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 CZDKQKOAHAICSF-JSAMMMMSSA-N 0.000 description 1
• MASIBAKBCLRNGA-UHFFFAOYSA-N 5-(4-chlorophenyl)-2-(2-dibenzofuran-2-yl-2-hydroxyiminoethyl)pentanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1C(=NO)CC(C(O)=O)CCCC1=CC=C(Cl)C=C1 MASIBAKBCLRNGA-UHFFFAOYSA-N 0.000 description 1
• GANZODCWZFAEGN-UHFFFAOYSA-N 5-mercapto-2-nitro-benzoic acid Chemical compound OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O GANZODCWZFAEGN-UHFFFAOYSA-N 0.000 description 1
• HMPGIJYWBLUOLP-UHFFFAOYSA-N 6-(1-adamantyloxycarbonylamino)-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]hexanoic acid Chemical compound C1C(C2)CC(C3)CC2CC13OC(=O)NCCCCC(C(=O)O)NS(=O)(=O)C(C=C1)=CC=C1C1=CC=C(Br)C=C1 HMPGIJYWBLUOLP-UHFFFAOYSA-N 0.000 description 1
• YJDMYRSPTINSPB-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-(c-dibenzofuran-2-yl-n-hydroxycarbonimidoyl)hexanoic acid Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1C(=NO)C(CC(O)=O)CCCC1=CC=C(Cl)C=C1 YJDMYRSPTINSPB-UHFFFAOYSA-N 0.000 description 1
• XEMNSYPBCAYANS-UHFFFAOYSA-N 6-(benzenesulfonamido)-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]hexanoic acid Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CCCCNS(=O)(=O)C1=CC=CC=C1 XEMNSYPBCAYANS-UHFFFAOYSA-N 0.000 description 1
• DXLFNVCVAVAXPH-UHFFFAOYSA-N 6-[(2-acetamido-1,3-thiazol-5-yl)sulfonylamino]-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]hexanoic acid Chemical compound S1C(NC(=O)C)=NC=C1S(=O)(=O)NCCCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=2C=CC(Br)=CC=2)C=C1 DXLFNVCVAVAXPH-UHFFFAOYSA-N 0.000 description 1
• PDDOKSGSYBRHKK-UHFFFAOYSA-N 6-[(4-acetamidophenyl)sulfonylamino]-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]hexanoic acid Chemical compound C1=CC(NC(=O)C)=CC=C1S(=O)(=O)NCCCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=2C=CC(Br)=CC=2)C=C1 PDDOKSGSYBRHKK-UHFFFAOYSA-N 0.000 description 1
• HTAPCROOMANAQD-UHFFFAOYSA-N 6-isoindol-2-ylhexanoic acid Chemical compound C1=CC=CC2=CN(CCCCCC(=O)O)C=C21 HTAPCROOMANAQD-UHFFFAOYSA-N 0.000 description 1
• 101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical class CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
• 208000019901 Anxiety disease Diseases 0.000 description 1
• 108010027006 Apolipoproteins B Proteins 0.000 description 1
• 102000018616 Apolipoproteins B Human genes 0.000 description 1
• 239000004135 Bone phosphate Substances 0.000 description 1
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical class [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
• GBJADNBEGCVFLZ-BBWFWOEESA-N C(CCCCCCC)[C@@H](C(=O)N1N[C@@H](CCC1)C(=O)NC)C[C@@H](C(=O)O)C Chemical compound C(CCCCCCC)[C@@H](C(=O)N1N[C@@H](CCC1)C(=O)NC)C[C@@H](C(=O)O)C GBJADNBEGCVFLZ-BBWFWOEESA-N 0.000 description 1
• LRIXQMXPAGKQHJ-YDALLXLXSA-N C1(=CC=CC2=CC=CC=C12)C[C@H](N)C(=O)O.NCC(=O)O Chemical compound C1(=CC=CC2=CC=CC=C12)C[C@H](N)C(=O)O.NCC(=O)O LRIXQMXPAGKQHJ-YDALLXLXSA-N 0.000 description 1
• CCXSXCWEMUWAMA-FOIFJWKZSA-N CCCc1ccc(CC[C@H](CC(CCCCNC(=O)c2ccccc2C(O)=O)C(O)=O)C(O)=O)cc1 Chemical compound CCCc1ccc(CC[C@H](CC(CCCCNC(=O)c2ccccc2C(O)=O)C(O)=O)C(O)=O)cc1 CCXSXCWEMUWAMA-FOIFJWKZSA-N 0.000 description 1
• NCWPSRGUQGCOGA-OZAIVSQSSA-N CCCc1ccc(CC[C@H](CC(CCCCNS(=O)(=O)c2ccccc2)C(O)=O)C(O)=O)cc1 Chemical compound CCCc1ccc(CC[C@H](CC(CCCCNS(=O)(=O)c2ccccc2)C(O)=O)C(O)=O)cc1 NCWPSRGUQGCOGA-OZAIVSQSSA-N 0.000 description 1
• DWXLLKMNGLVCDX-FOIFJWKZSA-N CCCc1ccc(CC[C@H](CC(CCCCc2nc3ccccc3[nH]2)C(O)=O)C(O)=O)cc1 Chemical compound CCCc1ccc(CC[C@H](CC(CCCCc2nc3ccccc3[nH]2)C(O)=O)C(O)=O)cc1 DWXLLKMNGLVCDX-FOIFJWKZSA-N 0.000 description 1
• QRKAUPVBKUJXQE-UHFFFAOYSA-N CN.OC(N1C(C=CC=C2)=C2NCC1)=O Chemical compound CN.OC(N1C(C=CC=C2)=C2NCC1)=O QRKAUPVBKUJXQE-UHFFFAOYSA-N 0.000 description 1
• JGSMRVUXXZXMGY-UHFFFAOYSA-N CN1CCCCCNC(=O)C(CCCC1)C2CCCCCCCCCCCC2 Chemical group CN1CCCCCNC(=O)C(CCCC1)C2CCCCCCCCCCCC2 JGSMRVUXXZXMGY-UHFFFAOYSA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 206010071200 Carbohydrate intolerance Diseases 0.000 description 1
• 208000006029 Cardiomegaly Diseases 0.000 description 1
• 208000014882 Carotid artery disease Diseases 0.000 description 1
• 206010008479 Chest Pain Diseases 0.000 description 1
• 108010004103 Chylomicrons Proteins 0.000 description 1
• RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000029816 Collagenase Human genes 0.000 description 1
• 108060005980 Collagenase Proteins 0.000 description 1
• 229920000742 Cotton Polymers 0.000 description 1
• KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
• MTFCXMJOGMHYAE-UHFFFAOYSA-N Ethyl piperazinoacetate Chemical compound CCOC(=O)CN1CCNCC1 MTFCXMJOGMHYAE-UHFFFAOYSA-N 0.000 description 1
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 108010023302 HDL Cholesterol Proteins 0.000 description 1
• 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
• 208000035150 Hypercholesterolemia Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 206010022998 Irritability Diseases 0.000 description 1
• NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 206010026673 Malignant Pleural Effusion Diseases 0.000 description 1
• 240000003183 Manihot esculenta Species 0.000 description 1
• 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
• 108090000855 Matrilysin Proteins 0.000 description 1
• 108010076497 Matrix Metalloproteinase 10 Proteins 0.000 description 1
• 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 description 1
• 108010016160 Matrix Metalloproteinase 3 Proteins 0.000 description 1
• 102000001776 Matrix metalloproteinase-9 Human genes 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 101150101095 Mmp12 gene Proteins 0.000 description 1
• AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
• 229910002651 NO3 Inorganic materials 0.000 description 1
• HMNXCXBRSOBSLW-JEDNCBNOSA-N N[C@@H](CCCC)C(=O)O.NCC(=O)O Chemical compound N[C@@H](CCCC)C(=O)O.NCC(=O)O HMNXCXBRSOBSLW-JEDNCBNOSA-N 0.000 description 1
• 238000011887 Necropsy Methods 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 102000056189 Neutrophil collagenases Human genes 0.000 description 1
• 108030001564 Neutrophil collagenases Proteins 0.000 description 1
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 208000001132 Osteoporosis Diseases 0.000 description 1
• 108090000854 Oxidoreductases Proteins 0.000 description 1
• 102000004316 Oxidoreductases Human genes 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 208000018262 Peripheral vascular disease Diseases 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 102000016611 Proteoglycans Human genes 0.000 description 1
• 108010067787 Proteoglycans Proteins 0.000 description 1
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
• 229940123934 Reductase inhibitor Drugs 0.000 description 1
• 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 description 1
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
• 101710108790 Stromelysin-1 Proteins 0.000 description 1
• 102100028848 Stromelysin-2 Human genes 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 206010042434 Sudden death Diseases 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• JJXQJRXVCKXJRM-NTZARQNWSA-N [1-[[(2s)-4-methyl-1-[[(2s)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-(phenylmethoxycarbonylamino)propyl]phosphonic acid Chemical compound C([C@@H](C(=O)NC)NC(=O)[C@H](CC(C)C)NC(CCNC(=O)OCC=1C=CC=CC=1)P(O)(O)=O)C1=CC=CC=C1 JJXQJRXVCKXJRM-NTZARQNWSA-N 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
• 229960001171 acetohydroxamic acid Drugs 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 229910052783 alkali metal Inorganic materials 0.000 description 1
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000000304 alkynyl group Chemical group 0.000 description 1
• 235000008206 alpha-amino acids Nutrition 0.000 description 1
• AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 229940024606 amino acid Drugs 0.000 description 1
• 235000001014 amino acid Nutrition 0.000 description 1
• 150000003862 amino acid derivatives Chemical class 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• ZXKINMCYCKHYFR-UHFFFAOYSA-N aminooxidanide Chemical compound [O-]N ZXKINMCYCKHYFR-UHFFFAOYSA-N 0.000 description 1
• 150000003863 ammonium salts Chemical class 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 229940030600 antihypertensive agent Drugs 0.000 description 1
• 230000036506 anxiety Effects 0.000 description 1
• 210000000709 aorta Anatomy 0.000 description 1
• 239000012736 aqueous medium Substances 0.000 description 1
• 239000007900 aqueous suspension Substances 0.000 description 1
• 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
• 125000004421 aryl sulphonamide group Chemical group 0.000 description 1
• 125000000732 arylene group Chemical group 0.000 description 1
• 235000010357 aspartame Nutrition 0.000 description 1
• SHZPNDRIDUBNMH-NIJVSVLQSA-L atorvastatin calcium trihydrate Chemical group O.O.O.[Ca+2].C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1.C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 SHZPNDRIDUBNMH-NIJVSVLQSA-L 0.000 description 1
• ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
• QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical compound C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 description 1
• 229950001858 batimastat Drugs 0.000 description 1
• UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
• 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
• 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• FYGUSUBEMUKACF-UHFFFAOYSA-N bicyclo[2.2.1]hept-2-ene-5-carboxylic acid Chemical compound C1C2C(C(=O)O)CC1C=C2 FYGUSUBEMUKACF-UHFFFAOYSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 238000012742 biochemical analysis Methods 0.000 description 1
• 238000002306 biochemical method Methods 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
• 238000009530 blood pressure measurement Methods 0.000 description 1
• DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 1
• MSZJEPVVQWJCIF-UHFFFAOYSA-N butylazanide Chemical compound CCCC[NH-] MSZJEPVVQWJCIF-UHFFFAOYSA-N 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
• 239000000920 calcium hydroxide Substances 0.000 description 1
• 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 125000005518 carboxamido group Chemical group 0.000 description 1
• 150000001735 carboxylic acids Chemical class 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 210000004027 cell Anatomy 0.000 description 1
• 206010008118 cerebral infarction Diseases 0.000 description 1
• 208000026106 cerebrovascular disease Diseases 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 125000001309 chloro group Chemical group Cl* 0.000 description 1
• 239000003240 coconut oil Substances 0.000 description 1
• 235000019864 coconut oil Nutrition 0.000 description 1
• RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
• 239000005516 coenzyme A Substances 0.000 description 1
• 229940093530 coenzyme a Drugs 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 229960002424 collagenase Drugs 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 229940000425 combination drug Drugs 0.000 description 1
• 230000002301 combined effect Effects 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 201000007717 corneal ulcer Diseases 0.000 description 1
• UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• NGFQXYLWQODUIL-UHFFFAOYSA-N cyclohexylazanide Chemical compound [NH-]C1CCCCC1 NGFQXYLWQODUIL-UHFFFAOYSA-N 0.000 description 1
• 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 230000000093 cytochemical effect Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• 239000000890 drug combination Substances 0.000 description 1
• 238000002592 echocardiography Methods 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• SLFUXNFVAANERW-UHFFFAOYSA-N ethyl hexanoate;potassium Chemical compound [K].CCCCCC(=O)OCC SLFUXNFVAANERW-UHFFFAOYSA-N 0.000 description 1
• LKHYFCSSVZVVNF-UHFFFAOYSA-N ethyl hexanoate;sodium Chemical compound [Na].CCCCCC(=O)OCC LKHYFCSSVZVVNF-UHFFFAOYSA-N 0.000 description 1
• 229940012017 ethylenediamine Drugs 0.000 description 1
• 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• TVFIYRKPCACCNL-UHFFFAOYSA-N furan-2-carboxamide Chemical compound NC(=O)C1=CC=CO1 TVFIYRKPCACCNL-UHFFFAOYSA-N 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 238000007446 glucose tolerance test Methods 0.000 description 1
• 235000011187 glycerol Nutrition 0.000 description 1
• 239000000665 guar gum Substances 0.000 description 1
• 125000004446 heteroarylalkyl group Chemical group 0.000 description 1
• 125000005549 heteroarylene group Chemical group 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• WMUQPCHZPNHRGM-UHFFFAOYSA-N hexanamide;hydrochloride Chemical compound Cl.CCCCCC(N)=O WMUQPCHZPNHRGM-UHFFFAOYSA-N 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 238000002657 hormone replacement therapy Methods 0.000 description 1
• 150000002430 hydrocarbons Chemical group 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 230000003601 intercostal effect Effects 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• BMFVGAAISNGQNM-UHFFFAOYSA-N isopentylamine Chemical compound CC(C)CCN BMFVGAAISNGQNM-UHFFFAOYSA-N 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
• 229960000201 isosorbide dinitrate Drugs 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 229940002661 lipitor Drugs 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
• 239000000347 magnesium hydroxide Substances 0.000 description 1
• 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 229950008959 marimastat Drugs 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 235000012054 meals Nutrition 0.000 description 1
• 229960003194 meglumine Drugs 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• GXHMMDRXHUIUMN-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O.CS(O)(=O)=O GXHMMDRXHUIUMN-UHFFFAOYSA-N 0.000 description 1
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
• OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
• AXLHVTKGDPVANO-UHFFFAOYSA-N methyl 2-amino-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound COC(=O)C(N)CNC(=O)OC(C)(C)C AXLHVTKGDPVANO-UHFFFAOYSA-N 0.000 description 1
• GSYSFVSGPABNNL-UHFFFAOYSA-N methyl 2-dimethoxyphosphoryl-2-(phenylmethoxycarbonylamino)acetate Chemical group COC(=O)C(P(=O)(OC)OC)NC(=O)OCC1=CC=CC=C1 GSYSFVSGPABNNL-UHFFFAOYSA-N 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 230000003562 morphometric effect Effects 0.000 description 1
• 238000013425 morphometry Methods 0.000 description 1
• 230000004899 motility Effects 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 208000031225 myocardial ischemia Diseases 0.000 description 1
• LXRAWBFAYXEXCY-UHFFFAOYSA-N n-hydroxy-2-[(2-methoxyphenyl)methyl-octylsulfonylamino]acetamide Chemical compound CCCCCCCCS(=O)(=O)N(CC(=O)NO)CC1=CC=CC=C1OC LXRAWBFAYXEXCY-UHFFFAOYSA-N 0.000 description 1
• WACQAUOWMWPNQS-UHFFFAOYSA-N n-hydroxy-2-[(4-methoxyphenyl)sulfonyl-nonylamino]acetamide Chemical compound CCCCCCCCCN(CC(=O)NO)S(=O)(=O)C1=CC=C(OC)C=C1 WACQAUOWMWPNQS-UHFFFAOYSA-N 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 238000011587 new zealand white rabbit Methods 0.000 description 1
• 239000006186 oral dosage form Substances 0.000 description 1
• 239000012044 organic layer Substances 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 239000006201 parenteral dosage form Substances 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
• 125000004344 phenylpropyl group Chemical group 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical group C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• RFIOZSIHFNEKFF-UHFFFAOYSA-N piperazine-1-carboxylic acid Chemical compound OC(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-N 0.000 description 1
• JSPCTNUQYWIIOT-UHFFFAOYSA-N piperidine-1-carboxamide Chemical compound NC(=O)N1CCCCC1 JSPCTNUQYWIIOT-UHFFFAOYSA-N 0.000 description 1
• 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 229960001495 pravastatin sodium Drugs 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
• 229960004919 procaine Drugs 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 description 1
• QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical class CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
• WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 238000013094 purity test Methods 0.000 description 1
• TXQWFIVRZNOPCK-UHFFFAOYSA-N pyridin-4-ylmethanamine Chemical compound NCC1=CC=NC=C1 TXQWFIVRZNOPCK-UHFFFAOYSA-N 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 238000009790 rate-determining step (RDS) Methods 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 235000021003 saturated fats Nutrition 0.000 description 1
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 150000004760 silicates Chemical class 0.000 description 1
• 230000000391 smoking effect Effects 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
• 229910000104 sodium hydride Inorganic materials 0.000 description 1
• 239000012312 sodium hydride Substances 0.000 description 1
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000008247 solid mixture Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 238000012289 standard assay Methods 0.000 description 1
• 238000009662 stress testing Methods 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 239000001384 succinic acid Substances 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 150000003457 sulfones Chemical class 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
• 125000003831 tetrazolyl group Chemical group 0.000 description 1
• 229940126585 therapeutic drug Drugs 0.000 description 1
• 230000008354 tissue degradation Effects 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 239000006211 transdermal dosage form Substances 0.000 description 1
• 150000003626 triacylglycerols Chemical class 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
• 235000021081 unsaturated fats Nutrition 0.000 description 1
• 229960004295 valine Drugs 0.000 description 1
• 230000002861 ventricular Effects 0.000 description 1
• 239000008096 xylene Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1